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Investigating Synthetic Lethal Interactions with the Wall Teichoic Acid Pathway of 
Staphylococcus aureus 
Abstract 
The peptidoglycan of many Gram-positive bacteria is densely functionalized with 
anionic glycopolymers called wall teichoic acids (WTAs).  Recent studies have shown that 
these polymers play crucial roles in cell shape determination, regulation of cell division, and 
other fundamental aspects of Gram-positive bacterial physiology. Furthermore, in pathogens 
they are important in host infection and play key roles in antibiotic resistance. In many cases, 
precise mechanisms for WTA involvement in these processes have not been established. In 
order to better understand the roles of WTAs in the biology of the human pathogen 
Staphylococcus aureus, we sought to identify their interactions with other cellular pathways. 
By employing a transposon screen, we found that lipoteichoic acid (LTA) synthesis, D-
alanylation of teichoic acids, cell wall stress sensors, CAAX-like proteases, and 
peptidoglycan biosynthesis were all synthetically lethal with depletion of WTAs in 
Staphylococcus aureus. Further investigations revealed that several genes required when 
WTAs were depleted were not essential when LTAs were removed. Unexpectedly, TA D-
alanylation, became essential in the absence of WTAs, but not LTAs. Examination of 
terminal phenotypes following WTA depletion revealed that strains lacking LTA D-alanine 
esters died from envelope rupture during ongoing cell division whereas strains lacking LTAs 
were unable to form Z rings, stopped dividing, and had altered PG biosynthesis. Finally, we 
designed and implemented parallel, pathway-specific chemical screens to identify inhibitors 
that specifically kill mutants deficient in WTAs or D-alanylation of TAs. In addition to 
elucidating new interactions between cell envelope pathways, and establishing distinct roles 
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LTAs and WTAs in the cell envelope of S. aureus, these experiments provide a list of 
potential targets and a strategy for identifying inhibitors for these targets, in compound 
combinations as therapeutics against antibiotic-resistant S. aureus infections.
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Chapter 1: Wall Teichoic Acid Biosynthesis and Function 
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1.1 Introduction 
Bacteria are surrounded by a complex cell envelope that performs a variety of 
functions (202). Cell envelopes are varied in structure, but all contain layers of peptidoglycan 
(PG), a cross-linked matrix of linear carbohydrate (glycan) chains connected to one another 
via covalent bonds between attached peptides (228). This PG matrix is essential for survival, 
and in gram-positive organisms it is densely functionalized with other polymers. Wall 
teichoic acids (WTAs) are the most abundant PG-linked polymers in many gram-positive 
organisms (166). They are intimately involved in many aspects of cell division and are 
essential for maintaining cell shape in rod-shaped organisms (211). WTAs are required for β-
lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA), and they modulate 
susceptibility to cationic antibiotics in several organisms (42; 44; 247). Due to their 
importance in pathogenesis, WTAs are possible targets for new therapeutics to overcome 
resistant bacterial infections. Here we review recent work on WTAs and discuss studies 
implicating the pathway as a therapeutic target. 
 
1.2 Teichoic Acid Definition 
Armstrong et al. discovered teichoic acids in 1958 while trying to determine the 
function of CDP-glycerol and CDP-ribitol in Lactobacillus arabinosus, Bacillus subtilis, and 
several other bacteria (9). The term teichoic acid encompasses a diverse family of cell 
surface glycopolymers containing phosphodiester-linked polyol repeat units (235). Teichoic 
acids include both lipoteichoic acids (LTAs), which are anchored in the bacterial membrane 
via a glycolipid, and WTAs, which are covalently attached to PG (166; 235) (Figure 1.1).  
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Figure 1.1: Teichoic acid polymers are located within the gram-positive cell wall. This 
schematic of the gram-positive cell wall shows that WTAs are covalently anchored to PG and 
LTAs are tethered to the membrane. The WTAs extend beyond the PG layer, whereas fully 
extended LTAs may not be able to reach past the PG layer. Abbreviations: LTA, lipoteichoic 
acid; PG, peptidoglycan; WTA, wall teichoic acid. 
1.3 Wall Teichoic Acid Backbone Structure 
WTAs are highly abundant modifications of gram-positive cell walls (165). In B. 
subtilis and S. aureus, it has been estimated that every ninth PG N-acetylmuramic acid 
(MurNAc) residue contains an attached WTA polymer containing 40 to 60 polyol repeats 
(20; 127). The total mass of WTAs in these and other organisms constitutes up to 60% of the 
cell wall (74; 217). Cryo-electron microscopy images suggest that, consistent with their 
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estimated length, S. aureus WTAs extend well beyond the PG layer (150; 151; 189). 
The WTA polymer can be divided into two components: a disaccharide linkage unit 
and a main chain polymer composed of phosphodiester-linked polyol repeat units (166) 
(Figure 1.2). The disaccharide linkage unit, which is highly conserved across bacterial 
species, is composed of N-acetylmannosamine (β1→4) N-acetylglucosamine 1-phosphate 
[ManNAc(β1→4)GlcNAc- 1P] with one to two glycerol 3-phosphate units attached to the C4 
oxygen of ManNAc (8; 127; 166). The anomeric phosphate of the linkage unit is covalently 
attached to PG via a phosphodiester bond to the C6 hydroxyl of MurNAc. The 
phosphodiester-linked polyol repeats extend from the GroP end of the linkage unit (166; 
235). 
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Figure 1.2:  WTA polymers share a common linkage unit but exhibit structural diversity in 
their repeat units. (a) The commonly characterized WTA linkage unit consists of a GroP-
ManNAc-GlcNAc-P that is covalently attached to peptidoglycan. Although the 
stereochemistry of the glycosidic linkage has not been clearly established, it is assumed to be 
retained as α on the basis of predicted enymatic catalysis. (b) Four different classes of WTA 
repeat units found in gram-positive bacteria as adapted from Naumova, et al. (165). 
Abbreviations: GalNAc, N-acetylgalactosamine; GlcNAc, N-acetylglucosamine; GroP, 
glycerol 3-phosphate; ManNAc, N-acetylmannosamine; MurNAc, N-acetylmuramic acid; P, 
phosphate; RboP, ribitol 5-phosphate. 
The best-characterized WTA structures contain repeat units of ribitol 5-phosphate 
(RboP) or glycerol 3-phosphate (GroP), but WTA monomer structures can be highly diverse, 
and many published structures are more unusual (75; 76; 165). Other WTA repeat units 
include variations of glycosylpolyol phosphate or glycosyl phosphate–polyol phosphate (165; 
166) (Figure 1.2). WTA structural diversity can exist within the same species, as in B. 
subtilis, in which strains 168 and W23 contain GroP and RboP repeat units, respectively. 
Lactobacillus plantarum has the ability to switch backbone composition (39). Furthermore, 
single strains of S. aureus and Bacillus coagulans can contain polymers with distinct repeats 
expressed simultaneously but at different levels (182; 226). WTA structural variations may 
represent adaptations to different environments. Relatedly, bacteria are known to modulate 
transcription of WTA biosynthetic genes in response to stress conditions (159). Despite their 
diversity, all WTAs contain a negatively charged anionic backbone and share common 
functions. 
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1.4 Tailoring Modifications of the Wall Teichoic Acid Polymer 
Additional WTA structural diversity arises from the presence or absence of 
substituents attached to the repeating monomers (Figure 1.3). The repeat unit hydroxyls can 
be tailored with cationic D-alanine esters or a variety of mono- or oligosaccharides, 
commonly glucose or GlcNAc (166). In RboP polymers, D-alanyl residues are installed at 
position 2 of ribitol and sugars are commonly found at position 4 (166; 226). D-Alanine ester 
content is variable and depends on several factors, including pH, salt concentration, and 
temperature (117; 166). In contrast, the WTA sugar substituents do not appear to fluctuate 
with changes in the cellular environment (53). These tailoring modifications are typically 
highly abundant. For example, nearly all of the RboP repeats in S. aureus contain O-GlcNAc 
substituents (117). Depending on the bacterial strain, the anomeric glycosidic linkage to the 
repeat unit can be exclusively α, exclusively β, or a mixture of the two (49; 75; 76; 163). 
Some S. aureus strains have been found to contain, in the same cell wall, two different 
poly(RboP) WTAs, one fully α-glycosylated and the other fully β-glycosylated (218). In B. 
subtilis W23 it was observed that some WTA strands were fully glycosylated, whereas other 
strands contained no sugar substituents (49). 
 
1.5 Wall Teichoic Acid Biosynthesis 
 
1.5.1 Overview 
Much of the early work to understand WTA biosynthesis used particulate enzyme 
preparations. Though this work enabled characterization of the enzymatic steps in WTA 
polymer formation, the identities of the enzymes responsible for these steps remained elusive 
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(235). Later, genetic analyses of temperature-sensitive and phage-resistant mutants led to the 
identification of the poly(GroP) WTA gene cluster in B. subtilis 168 and the poly(RboP) 
WTA gene cluster in B. subtilis W23 (119; 253). Sequence analysis led to proposals for the 
enzymatic activity encoded by each gene (136; 166; 235). However, it proved challenging to 
fully characterize the pathway using genetics because many of the biosynthetic genes are 
essential (25; 26; 58; 59; 125). Efforts to characterize WTA enzymes biochemically were 
hampered because the substrates contain 55-carbon lipid chains that make them difficult to 
handle. Moreover, these lipid-linked substrates are present in very low abundance and cannot 
be isolated in useful quantities from bacterial cells. The development of chemoenzymatic 
methods to make WTA substrates has not only allowed elucidation of biosynthetic pathways 
but also permitted mechanistic studies on purified teichoic acid enzymes in the absence of 
membranes (40; 43; 93; 196; 201; 255). 
 
1.5.2 Linkage Unit Synthesis 
In 1978 Archibald and colleagues used electron microscopy to show that WTA 
synthesis begins in the cytoplasm at the wall-membrane interface and that the WTA polymer 
subsequently appears on the outer surface of the cell (6; 235). TagO catalyzes the first 
synthetic step: the transfer of GlcNAc-1-P from UDP-GlcNAc to a membrane-anchored 
undecaprenyl phosphate carrier lipid, an intermediate shared with PG biosynthesis (191; 
204). The TagO product is used in the synthesis of several B. subtilis 168 cell wall polymers, 
including the major WTA [poly(GroP)], the minor teichoic acid (TA) [poly(glucosyl N-
acetylgalactosamine 1-phosphate)], and teichuronic acid [poly(glucuronyl N-
acetylgalactosamine)] (204). Consequently, the first committed step in WTA biosynthesis is 
	  	   8	  
the transfer of ManNAc from UDP-ManNAc to the C4 hydroxyl of GlcNAc to form the 
ManNAc(β1→4)GlcNAc disaccharide, catalyzed by TarA (57; 93; 255). The UDP-ManNAc 
donor sugar is derived from UDP-GlcNAc via MnaA (yvyH), an epimerase that catalyzes 
stereochemical inversion at the C2 position (205). TagB, a glycerophosphotransferase, 
catalyzes the transfer of a GroP unit from CDP-glycerol to the C4 position of ManNAc (27; 
93). These first three steps to complete the synthesis of the WTA linkage unit are highly 
conserved across all strains characterized thus far (Figure 1.3). After these steps, WTA 
pathways diverge. 
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Figure 1.3: In different organisms, WTA biosynthesis begins with the same initial steps but 
then the pathways diverge. (a) The initial steps to WTA polymer formation that have been 
found in all pathways characterized thus far. (b-d) The end-stage intracellular steps to form 
the WTA poylmer in (b) Bacillus subtilis, (c) B. subtilis W23, and (d) Staphylococcus 
aureus. TarIJ reactions to form CDP-ribitol exist in both B. subtilis W23 and S. aureus. The 
α or β within the sugar denotes the stereochemistry of attachment. We have shown α- and β -
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GlcNAc attachment to S. aureus occurring on the same strand, but it is possible that the TarS 
and TarM enzymes do not attach GlcNAc to the same polymer. 
1.5.3 Poly(Glycerol 3-Phosphate) Wall Teichoic Acid Synthesis 
The genes encoding proteins involved in poly(GroP) WTA synthesis are annotated as 
tag genes (teichoic acid glycerol) (36). B. subtilis 168 is the most studied of the poly(GroP) 
WTA–producing organisms (Figure 1.3). After the action of TagO, TagA, and TagB to 
complete synthesis of the linkage unit, TagF adds 45–60 GroP units to the TagB product to 
assemble the polymer (145; 178; 195; 196; 201). The GroP moiety originates from the 
activated precursor CDP-glycerol, which is synthesized by TagD, a cytidylyltransferase that 
catalyzes the transfer of L-α-glycerol 3-phosphate to CTP, releasing pyrophosphate (172). 
Although the Tag enzymes from B. subtilis 168 remain the most characterized of the 
poly(GroP) WTA biosynthetic enzymes, homologs have been identified and loosely 
characterized in other bacteria known to contain poly(GroP) WTAs, including Enterococcus 
faecalis, L. plantarum, Staphylococcus epidermidis, and several species of Streptomyces (60; 
65; 85; 158; 164). 
In 2010, Strynadka and colleagues published the first and so far only crystal structure 
of a teichoic acid enzyme involved in polymer synthesis (145). The structure showed that S. 
epidermidis TagF possesses a GT-B glycosyltransferase fold and an extended open active site 
that appears capable of accommodating the rebinding of CDP-glycerol without product 
release. Whereas this observation suggests a processive mechanism, kinetic studies found 
that polymer length depended on the ratio of CDP-glycerol to lipid acceptor, supporting a 
distributive mechanism (178; 196; 201). The crystal structure of TagF should allow for 
further mechanistic studies on this class of phosphotransferases. TagB and TagF share 50% 
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similarity in their catalytic domains, but features governing primase versus polymerase 
activity await identification. 
1.5.4 Poly(Ribitol 5-Phosphate) Wall Teichoic Acid Synthesis 
Enzymes making poly(RboP) WTAs are designated Tar for teichoic acid ribitol (36), 
but it should be noted that TarO, TarA, TarB, and TarD have the same biochemical functions 
as TagO, TagA, TagB, and TagD, respectively. In S. aureus, following formation of the 
lipid-PP-ManNAc- GlcNAc-GroP product by TarO, TarA, and TarB, poly(RboP) synthesis 
continues with the TarF- mediated transfer of a (predominantly) single unit of GroP from 
CDP-glycerol, synthesized by TarD (14; 40; 43; 157; 237). As described above, the synthesis 
of poly(GroP) WTAs requires a GroP primase (TagB) as well as a GroP polymerase (TagF), 
and it was proposed that poly(RboP) WTA synthesis in S. aureus requires both a RboP 
primase and a RboP polymerase to make the main chain polymer (136; 185). Recent work 
has shown, however, that S. aureus contains a single enzyme, TarL, that primes the linkage 
unit and then attaches more than 40 RboP units to complete the polymer (43; 157; 177) 
(Figure 3). The CDP-ribitol substrate utilized by TarL is made by the combined action of 
TarI, a cytidylyltransferase, and TarJ, an alcohol dehydrogenase (176; 257). All S. aureus 
strains contain two sets of tarIJL genes (the second set is designated tarI′J′K) (185). The 
significance of these duplications is still unclear (157; 177; 185; 211; 247). 
Whereas poly(GroP) WTA biosynthesis has been fully characterized in only one 
organism, B. subtilis 168, poly(RboP) WTA biosynthesis has been characterized in both B. 
subtilis W23 and S. aureus (40; 43) (Figure 1.3). These two organisms produce very similar 
poly(RboP) WTAs, which differ only in the number of GroP repeats in the linkage unit (one 
versus two) and in the sugar tailoring modifications (the addition of Glc versus GlcNAc) 
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(166; 251). Both organisms appear to contain the same tar genes (136; 185), but their WTA 
biosynthetic pathways differ. Although S. aureus uses a single enzyme to prime the linkage 
unit and build the RboP polymer chain, B. subtilis W23 requires an RboP primase, TarK (40; 
157). Furthermore, TarK acts directly on the TagB product. Thus, B. subtilis W23 does not 
require the enzymatic activity of TarF even though it contains a tarF gene. In S. aureus tarF 
is essential, but genetic analysis has established that B. subtilis tarF is neither essential nor 
transcribed under laboratory culture conditions (40). The WTA polymer in B. subtilis W23 is 
completed by the RboP polymerase TarL, which can attach upward of 40 RboP units (251). 
Thus, B. subtilis W23 TarL is not a bifunctional primase-polymerase like its S. aureus 
homolog but can utilize only WTA lipid-linked substrates that are primed with RboP by 
TarK (40; 157). 
The biochemical and genetic studies of WTA biosynthesis described above have 
substantially expanded our understanding of how WTA polymers are made, but they also 
highlight challenges in predicting enzymatic pathways from genome sequences. Other 
pathways will most likely begin with the same initial steps but may then diverge (Figure 1.3). 
In principle, the presence of tagD and tarIJ genes, required to make CDP-glycerol (tagD) and 
CDP-ribitol (tarIJ) substrates, should facilitate prediction of WTA polymer composition (18; 
65; 217). It should be noted, however, that strains containing both types of genes may 
produce only one type of polymer. For example, some strains of L. plantarum that make only 
poly(GroP) polymers contain both tarIJKL and tagDF homologs, but the tarIJ gene 
homologs are not transcribed (39; 217). More perplexing is a recent report of an E. faecalis 
strain that makes a WTA poly(RboP) polymer but does not have a tarJ homolog (214). 
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1.5.5 Attachment of Sugars to the Polyol Chain 
Data suggests WTA glycosylation occurs inside the cell after polymer synthesis is 
complete prior to WTA export to the cell surface (4; 42). In the past few years several WTA 
glycosyltransferases have been identified. In B. subtilis 168, TagE modifies WTAs with α-
glucose using UDP-glucose as a donor substrate (4; 17). In B. subtilis W23, TarQ attaches β-
glucose units to poly(RboP) WTAs (42). In S. aureus, RboP WTA α-O-GlcNAc 
modifications are installed by TarM (248), and β-O-GlcNAc modifications are installed by 
TarS (42). As mentioned above, WTAs extracted from cells appear to be heavily modified 
with sugars of the same stereochemistry or not modified at all  (49; 75; 76; 218), suggesting 
that the glycosyltransferases are processive enzymes that fully glycosylate WTAs. 
Processivity may ensure that individual polymers are densely modified and, in organisms that 
contain more than one glycosyltransferase, may also prevent the attachment of sugars of 
different stereochemistries to the same polymer. The presence or absence of sugars and the 
glycosidic linkage conformation affect polymer structure and likely influence interactions 
with other components in the cell envelope or at the cell interface (24). Strains lacking 
modifications have altered phenotypes with regard to antibiotic susceptibility and virulence 
(42; 247). Although progress has been made with regard to the roles of the WTA sugar 
substituents, numerous questions remain. 
 
1.5.6 Polymer Export 
The final steps in the WTA biosynthetic pathway, those following polymer formation 
and sugar tailoring, are not as clearly defined as are earlier steps. For both poly(GroP) and 
poly(RboP) WTA polymers, the polymer is translocated through the membrane by a two-
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component ABC (ATP-binding cassette) transporter (TagGH and TarGH, respectively) 
(137). TagH, containing an ATPase domain, provides energy to drive a conformational 
change in the transmembrane component, TagG, which somehow facilitates translocation 
across the membrane (137; 189). The WTA transporter exports polymers containing main 
chains that can be more than ten times longer than the width of the lipid bilayer. In principle, 
there are two models for how export may occur: one involves a threading mechanism in 
which the polymer is fed through the transporter from the nonreducing end, eventually 
pulling the linkage unit across; the other involves a flipping mechanism in which the lipid-
PP-GlcNAc-ManNAc linkage unit is somehow flipped across the membrane, with the 
polymer chain following (Figure 1.4). The former model is conceptually simpler, but 
experimental studies support the latter model in that they show that the linkage unit, and not 
the main chain, is recognized by TagGH (39; 199). It is not known whether translocation 
occurs concomitantly with or following polymerization. Reconstitution of the translocation 
process in proteoliposomes would provide valuable mechanistic insight and may be possible 
now that all previous steps have been characterized and enzymes to make the precursors are 
available. 
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Figure 1.4: WTA polymer flipping and attachment to PG in Bacillus subtilis 168 proceeds 
through a series of enzymes. In this schematic, the poly(GroP) WTA polymer is transported 
through the cell membrane by TagGH. Homology suggests that the energy generated by 
TagH ATP hydrolysis drives a conformational change that allows for polymer transport. 
TagGH can presumably either (a) thread the polymer through the membrane by the 
nonreducing end or (b) recognize the disaccharide linkage unit and flip the polymer across. 
(c) Following transport, the poylmer is covalently attached to PG by TagTUV. It is unknown 
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whether the TagTUV enzymes work independently or together to ligate WTA to PG. The 
energy source for this ligation reaction, which we designated here as ATP hydrolysis, is 
undetermined. It remains unknown whether extracellular D-alanylation by DltABCD occurs 
before or after WTAs are covalently attached to PG. 
1.5.7 Wall Teichoic Acid Attachment to Peptidoglycan 
Once the polymer is outside the cell, the final stage of WTA biosynthesis is the 
formation of a phosphodiester linkage between the WTA polymer and the C6 hydroxyl of the 
PG MurNAc unit. On the basis of genetic evidence, a set of redundant enzymes, TagTUV, 
was recently proposed to be responsible for catalyzing this coupling reaction in B. subtilis 
168 (121), and similar evidence supports a related function for three homologous enzymes in 
S. aureus  (66; 112; 169) (Figure 4). TagT has geranyl pyrophosphatase activity (70; 121), 
which is presumed to be a surrogate for attack of the WTA phosphodiester bond by the C6 
MurNAc hydroxyl of PG, but an authentic coupling reaction must be reconstituted to confirm 
the proposed WTA ligase activity. 
The question of when and where WTAs are synthesized and attached to PG is still 
debated. Decades ago, some studies suggested the WTA polymer is attached to nascent (new) 
PG, whereas others indicated that it may be attached to mature (old) PG. Still others 
suggested it can be attached to concurrently synthesized as well as preexisting PG (38; 152; 
216; 235; 244). Recently, the timing and location of WTA synthesis has been revisited. In 
cryo-electron microscopy images, Matias & Beveridge (149-151) identified densely staining 
material at the septa of B. subtilis and S. aureus as WTA and proposed that WTAs are 
attached to new PG during cell division. Consistent with this hypothesis, this densely staining 
material disappears in a time-dependent fashion when the first step in WTA synthesis is 
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inhibited (44). Furthermore, studies using fluorescent protein fusions show that WTA 
biosynthetic proteins localize predominantly to the septum in B. subtilis and S. aureus (11; 
27; 86), suggesting that WTAs are attached to nascent PG during cell division (septum 
formation). However, other studies suggest that WTAs are attached to older PG (7; 200). 
Fluorescently labeled concanavalin A, a lectin reported to bind to α-GlcNAcylated WTAs, 
was used to probe the location of WTAs in S. aureus. Fluorescent concanavalin A bound to 
the half of the cell containing old PG but not to the half containing PG produced during cross 
wall formation (cell division) (7; 200). Additional studies using alternative detection methods 
are required to resolve the location of WTA attachment. 
 
1.5.8 D-Alanylation of the Wall Teichoic Acid Repeat Unit 
Attachment of D-alanine esters to WTAs is an important mechanism by which 
bacteria modulate surface charge (53). Unlike glycosylation, which occurs inside the cell, D-
alanylation occurs following export of WTAs to the cell surface. Four enzymes, encoded by 
the dltABCD operon, attach D-alanines to both LTAs and WTAs (128; 153; 175) (Figure 
1.5). DltA resembles the adenylation domains of nonribosomal peptide synthetases. It is 
responsible for activating D-alanine as an AMP ester (104) and then transferring the 
aminoacyl adenylate to DltC. DltC possesses a pantothenate cofactor that forms a thioester 
with D-alanine through nucleophilic attack of the sulfhydryl on the mixed anhydride (105; 
227). What happens after DltC is charged with D-alanine is unclear, but it involves both DltB 
and DltD (Figure 1.5). DltB, which contains several predicted membrane-spanning helices, is 
an uncharacterized membrane protein of the membrane-bound O-acetyltransferase (MBOAT) 
family. DltD is a membrane-anchored protein shown to possess a short, cytoplasmic N-
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terminus and a large extracellular C-terminal domain (188). DltD was shown to hydrolyze D-
alanine from acyl carrier protein, which is normally involved in fatty acid biosynthesis; on 
this basis DltD was suggested to have an editing function and to remove D-alanine from 
mischarged acyl carrier protein (61). It was also shown to modestly accelerate the rate of 
transfer of D-alanine to DltC, suggesting an accessory role in the transfer reaction (61). 
These proposals for DltD require it to function in the cytoplasm, which is inconsistent with 
its topology (188). At this point, the specific function of DltD is unclear, though recent 
evidence shows its direct interaction with YpfP, LtaA, and LtaS of the LTA biosynthetic 
pathway (187). 
Early experiments proposed on the basis of pulse-chase radiolabeling that D-alanines 
are transferred to LTAs by DltC and then to WTAs in an isoenthalpic transesterification 
reaction (101). Two lines of evidence support such a mechanism: D-alanyl esters can be 
transferred between LTAs of differing lengths in nonnative micelles without an enzyme 
catalyst, though the reaction is slow (48), and an LTA-deficient S. aureus mutant was found 
to have highly reduced D-alanylation of its WTAs (188). Alternatively, D-alanyl esters could 
be transferred back from LTAs to DltC and then to WTAs (123). Because this transfer 
reaction requires bacterial membranes, other factors may also play a role in the process. DltB 
is also required for D-alanylation, and it has been suggested to facilitate membrane 
translocation of D-alanine-charged DltC so that it can serve as the direct donor to LTA (166). 
DltC has not been identified in any proteomic analyses of secreted proteins, and the evidence 
that it serves as the direct D-alanylation donor is limited (68; 123; 166). Recent experiments 
confirmed that DltC is exclusively cytoplasmic (188). An alternate hypothesis was proposed 
by Heaton & Neuhaus, where undecaprenyl phosphate could serve as a substrate for D-
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alanylation and subsequent flipping by DltB (83; 105). They cited homology between this 
protein and undecaprenol phosphate transferases, as well as sensitivity of the reaction to 
tunicamycin and amphomycin. Other D-alanylated phospholipids have been identified that 
could theoretically serve as donors, including D-alanylcardiolipin and D-
alanylphosphatidylglycerol, however, these lipids have not been detected innately in S. 
aureus (203). This proposal is more consistent with predicted enzymatic functionality for 
DltB as an MBOAT family protein. Furthermore, it was recently shown that Gram-negative 
organisms attach positively-charged amino acids to LPS through proteins 
analogous/homologous to the Dlt pathway, including one with an annotated lysophospholipid 
acyltransferase (LPLAT) domain (103). Although it is clear that D-alanylation of LTAs and 
WTAs requires the same biosynthetic machinery, many questions remain regarding the 
enzymology of the process. 
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Figure 1.5: D-alanylation of teichoic acids. The DltABCD machinery is responsible for the 
activation and attachment of D-alanines to extracellular teichoic acids. Many questions 
remain regarding the roles of DltB and DltD, the nature of their substrates, and whether D-
alanine transesterification is enzymatically catalyzed. 
1.6 Nonessential and Conditionally Essential Wall Teichoic Acid Genes 
Deletion of tagO or tagA, the first two genes in the WTA biosynthetic pathway, 
produces bacteria lacking WTA polymers. These bacteria display a range of defects, but are 
viable in traditional laboratory conditions. With the exception of the tailoring enzymes, 
however, most of the downstream WTA genes are essential, and their deletion results in a 
lethal phenotype unless flux into the WTA pathway is blocked at an early stage (58; 59). The 
lethality of a late-stage block may be due to accumulation of toxic intermediates in the cell or 
to depletion of cellular pools of undecaprenyl phosphate, which is also required for the 
synthesis of PG (57-59; 211; 247). Conditionally essential genes are found in pathways for 
other cell wall polysaccharides that are synthesized on the undecaprenyl phosphate carrier 
lipid. For example, deletion of late-stage genes involved in synthesis of the capsular 
polysaccharide of Streptococcus pneumonia generates bacteria with suppressor mutations in 
the initiating enzyme that turns off capsule production (116; 245). 
 
1.7 Roles of Wall Teichoic Acids 
WTA polymers play numerous, varied roles in the cell wall owing to their location, 
abundance, and polyanionic nature (Figure 1.6). The molecular mechanisms underlying their 
many critical functions are not well understood. Genetic and small-molecule tools are 
enabling more detailed studies to elucidate these mechanisms. 
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Figure 1.6: Teichoic acids are responsible for a wide variety of functions involved in cell 
division, charge homeostasis, and infection. 
1.7.1 Regulation of Cell Morphology and Division 
Bacteria lacking WTAs grow slower than wild-type bacteria, and they clump in 
solution. These strains exhibit numerous morphological abnormalities, including a 
nonuniform thickening of the PG cell wall, increased cell size, and defects in septal 
positioning and number (7; 44; 52; 58; 171; 200). Furthermore, rod-shaped bacteria such as 
B. subtilis and Listeria monocytogenes lose their shape, becoming spherical (25; 36; 72; 77; 
204; 205). These phenotypes imply that WTAs are necessary for proper localization, 
assembly, and/or activation of cell wall elongation and division machinery. Consistent with 
this idea, many WTA and PG biosynthetic enzymes have been shown to colocalize and 
physically interact in B. subtilis (86; 121). 
Evidence for functional interactions between WTAs and PG machinery comes from 
S. aureus, in which the putative PG cross-linking enzymes PBP4 and FmtA lose septal 
localization in the absence of WTAs (11; 184). This mislocalization correlates with 
decreased PG cross-linking found in ΔtarO mutants (200). In addition, Campbell et al. 
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showed that TarO inhibitors potentiate β-lactams in MRSA strains, indicating a functional 
connection between the PG and WTA biosynthetic pathways (44). Farha et al. used a panel 
of β-lactams to argue that this synthetic lethality was specifically due to combined disruption 
of the PG cross-linking enzymes PBP2 (via β-lactams) and PBP4 (via WTA biosynthesis 
inhibition) (80). Although many details remain to be clarified, there is considerable evidence 
that WTAs regulate the function of PG biosynthetic machinery, and the recruitment of cell 
wall assembly proteins is one mechanism through which they do so. 
 
1.7.2 Regulation of Autolytic Activity 
The failure of mutants to effectively septate and separate during cell division 
implicates WTAs in coordinating the localization, stability, and/or activity of PG lytic 
proteins. Strains lacking WTAs have altered endogenous autolysin expression profiles and 
increased autolysis rates (31; 146; 200; 236). In vitro studies performed with purified LTAs, 
enzymes, and cell wall substrates explain these observations using a recruitment model, in 
which polyanionic phosphate backbones bind and sequester positively charged autolysins 
(29; 84; 166). Positively charged D-alanyl esters help mask this charge and free autolysins to 
degrade PG. This model requires WTAs to be either absent from the septum or present in a 
highly D-alanylated state, as autolytic activity must be regulated to ensure separation 
specifically at the cross wall during cell division (249). Recent studies support an exclusion 
model (89; 200). Finally, others have proposed that WTAs could indirectly modulate enzyme 
activity through ion chelation (13; 31; 107). Whether directly or indirectly, or by recruitment 
or exclusion, WTAs clearly play a role in the localization of autolytic enzymes (89; 184; 
200). 
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1.7.3 Regulation of Ion Homeostasis 
It is thought that WTAs can bind extracellular metal cations by extending beyond the 
PG layer (122; 242). WTAs have a high affinity for metals, and their biosynthesis is 
upregulated under metal limitation (13; 75). WTAs also bind protons, and cells lacking 
WTAs have a 23% decrease in their proton binding capacity (31). Although WTAs do not 
influence the pH gradient across the cell wall, it has been suggested that they can create 
localized changes in pH, indirectly modulating the function of some enzymes (e.g., 
autolysins) (31). WTA ion binding is also thought to minimize repulsion between nearby 
phosphate groups, which can affect polymer structure and therefore cell wall integrity (122; 
242). D-Alanylation masks negatively charged sites on the polymer, reducing WTAs’ 
binding capacity for cations (107). Some have also speculated that ion binding to WTAs 
could help prevent fluctuations in osmotic pressure between the inside and the outside of the 
cell (7; 107; 211). 
 
1.7.4 Protection from Host Defenses and Antibiotics 
WTAs and their attached substituents contribute to bacterial cell surface charge and 
hydrophobicity, which in turn affect binding of extracellular molecules. By affecting cell 
surface characteristics, WTAs therefore play a role in protecting bacteria from various threats 
and adverse conditions. In the absence of WTAs, bacteria are sensitive to high temperatures 
and unable to grow in high-salt media, indicating that WTAs are involved in temperature 
tolerance and osmotic stress (11; 109; 205; 225). WTA-deficient cells are more susceptible to 
human antibacterial fatty acids, presumably because hydrophobic antibacterial fatty acids 
penetrate the less hydrophilic mutant cell wall more easily and bind more efficiently to the 
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cell membrane, where they can cause damage (126). 
Preventing D-alanylation through gene deletion removes D-alanine esters from both 
LTAs and WTAs; consequently, researchers have not yet been able to identify roles specific 
to each polymer. Nevertheless, it has been established that teichoic acid D-alanylation 
protects against host-defense mechanisms (130; 131). S. aureus lacking D-alanine has an 
increased susceptibility to phagocytes, to neutrophil killing (53), and to lysostaphin and 
lysozyme (180). A reduction in the D-alanyl content of the cell wall results in increased 
susceptibility to glycopeptide antibiotics and to certain cationic antimicrobial peptides 
(CAMPs) (53; 179; 180; 220; 231). It was reasoned that the absence of D-alanyl esters 
increases the overall negative cell surface charge (220), attracting cationic molecules and 
thus increasing susceptibility to CAMPs. Accordingly, B. subtilis and S. aureus lacking 
teichoic acid D-alanine modifications bind more positively charged cytochrome c than their 
wild-type counterparts do (179; 236). In group B streptococci, however, D-alanylation shows 
little influence on the surface association of fluorescently labeled CAMPs (192). These data 
suggest that charge effects are not solely responsible for the observed changes in CAMP 
susceptibility. Saar-Dover et al. suggested that the increased cell wall density observed in 
strains with D-alanylation prevents penetration of CAMPs, thereby conferring protection 
(192). The effect of TA D-alanylation on susceptibility toward other drugs appears variable. 
In both B. subtilis and S. aureus, deletion of dltA rendered the bacteria more sensitive to 
methicillin and a subset of other β-lactams, but more resistant to others (42; 236). However, a 
S. aureus transposon mutant in dltB possessed increased resistance to methicillin (162). 
Studies in B. subtilis have revealed that TA D-alanylation plays a role in the stability and 
folding of cell envelope proteins as well as signaling by cell envelope stress two-component 
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sensors, which may be one mechanism by which D-alanines have varying effects on 
antibiotic susceptibility (113; 114). 
Blocking WTA synthesis renders B. subtilis and MRSA sensitive to β-lactam 
antibiotics (42; 44; 81; 146; 179; 210; 236). Recent studies have replicated this sensitivity 
through the specific removal of WTA β-GlcNAc modifications (42). It has been speculated 
that the WTA β-GlcNAc moieties scaffold proteins involved in resistance. Accordingly, 
recent work has shown that S. aureus WTAs specifically interact with PBP2A (184), the 
resistant transpeptidase found in MRSA. Because WTA glycosyl substituents are also 
receptors for phage (17; 246), there is a precedent for WTA sugar residues mediating protein 
binding. It is possible that glycosylated WTAs function as ligands for cell surface proteins 
with carbohydrate recognition sites. 
 
1.7.5 Effects on Adhesion and Colonization 
The presence of WTAs and their D-alanyl esters influences bacterial interactions with 
various surfaces (166). WTA-deficient cells have a reduced capability to form biofilms (98; 
109; 225; 231). Removal of D-alanine esters also decreases biofilm formation and bacterial 
adhesion to plastic and glass surfaces. Decreased adherence is potentially linked to the 
resultant increase in negative cell surface charge creating increased repulsive forces between 
bacteria and a stratum (98; 109). 
In 1980, Aly et al. showed a 71% reduction of S. aureus binding to nasal epithelial 
cells that were preincubated with teichoic acid (5). Since that time, several animal studies 
have established that bacteria lacking teichoic acid D-alanine esters or WTAs are attenuated 
in host colonization and infection (53; 81; 131; 209; 210; 231; 233; 237; 238; 241). 
	  	   26	  
Lactobacilli lacking teichoic acid D-alanylation colonize mice gastrointestinal tracts at 1% of 
wild-type levels (231). Similarly, WTA-free S. aureus cells colonize rat nares at levels 90% 
lower than those of wild-type S. aureus, and in rabbits these mutant cells were unable to 
proliferate to adjacent organs (237; 241). Teichoic acid D-alanine esters are considered 
virulence factors, because their deletion attenuates pathogenicity but does not cause major 
cellular defects under laboratory growth conditions (7; 25; 44; 46; 52). WTAs have also been 
categorized as virulence factors, although they exhibit such profound defects in vitro that 
they may be better described as “in vivo essential” (50; 240). The decreased ability of WTA 
null mutants to survive in challenging host environments is due to the combined effects of an 
inability to adhere to host tissue, an increased susceptibility to host defenses, and cell 
division defects (131; 166; 231; 239). 
 
1.8 The Wall Teichoic Acid Pathway as an Antibiotic Target 
The vital roles of WTAs in physiology and pathogenesis promote this pathway as a 
target for antibacterial drugs and vaccines (211; 239). The WTA pathway contains three 
distinct target categories: antivirulence targets, β-lactam potentiator targets, and essential 
targets (Figure 1.7). 
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Figure 1.7: WTA biosynthetic enzymes are potential antibiotic targets. The schematic shows 
the three types of antibacterial targets present in the Staphylococcus aureus WTA pathway. 
Enzymes that are traditional antibiotic targets (tan), β-lactam potentiators (blue), or 
antivirulence antimicrobial targets (green) are boxed. The three chemical structures 
illustrated are small molecules known to inhibit WTA enzymes TarO, TarG, and DltA. 
1.8.1 Antivirulence Targets 
Proponents of virulence factors as antibacterial targets argue that resistance to 
virulence factor inhibitors is less likely to emerge, because there is no selection pressure for 
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survival (50). Although some argue that these inhibitors are unable to cure established 
infections and may create unforeseen in vivo host selection pressures, it is nonetheless worth 
investigating virulence factor targets, particularly for resistant pathogens. Enzymes of the dlt 
operon are targets for antivirulence agents because strains lacking teichoic acid D-alanine 
esters are strongly attenuated in animal infection models but show minimal growth defects 
under laboratory growth conditions (239). A DltA inhibitor was reported in 2005 but was not 
further optimized and is likely not specific (153). The enzymes involved in initiating WTA 
polymer synthesis, TarO and TarA, have also been described as virulence factor targets, but 
as noted above, these deletion strains are more than attenuated in animal hosts: they are 
nonviable (237). Hence, inhibitors of these initiating enzymes may behave more like 
traditional antibiotics in vivo, although this remains to be established. 
The natural product tunicamycin inhibits TarO at very low concentrations (44; 102; 
181), but at higher concentrations it also blocks MraY, an essential UDP-MurNAc-
pentapeptide transferase involved in PG biosynthesis (183). Tunicamycin has been used to 
probe the effects of inhibiting WTA biosynthesis in bacteria; unfortunately, however, it 
cannot be used in animals because it inhibits GPT, an essential phosphotransferase involved 
in eukaryotic N-linked glycan biosynthesis (183). Hence, there is still a need for specific 
nontoxic inhibitors that target TarO, TarA, and Dlt enzymes for use in infection models. 
 
1.8.2 β-Lactam Potentiator Targets 
β-Lactams are one of the safest and most widely used classes of antibiotics (91), and 
there is considerable interest in compounds that restore β-lactam sensitivity to resistant 
microorganisms. Β-Lactamase inhibitors, for example, have been highly successful as 
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components of compound combinations to treat many β-lactam resistant infections (91). Β-
Lactam resistance in MRSA is not mediated by β-lactamases but by the resistant 
transpeptidase PBP2A (254). Because the activity of this transpeptidase depends on the 
function of various host factors, compound combinations are possible as therapeutic 
modalities (254). TarO, TarA, and TarS are β-lactam potentiator targets. Unlike ΔtarO and 
ΔtarA strains, ΔtarS mutants divide normally and do not show appreciable growth defects 
(42). Furthermore, they are not strongly attenuated in virulence. Hence, TarS inhibitors 
should act exclusively as potentiators, whereas inhibitors of TarO and TarA would serve as 
both β-lactam potentiators and antivirulence agents. A cell-based high-throughput β-lactam 
potentiation screen recently identified the clinically used antiplatelet drug ticlopidine as a 
TarO inhibitor, although target selectivity was not demonstrated (81). It should also be 
possible to identify TarS inhibitors from β-lactam potentiation screens, as they can be readily 
discriminated from TarO or TarA inhibitors on the basis of their cellular effects (42). 
 
1.8.3 Traditional Antibiotic Targets 
Inhibitors of the essential late-stage WTA biosynthetic enzymes TarB through TarH 
should have lethal effects on bacterial cells and thus would be akin to traditional antibiotics. 
Late-stage WTA pathway inhibitors (e.g., targocil) were discovered by screening a ΔtarO 
mutant and a wild-type strain against the same library to identify compounds that selectively 
killed the wild-type strain. All identified compounds inhibited TarG (138; 212; 233). The 
identification of several different inhibitors of TarG indicates that this may be a druggable 
target. This may indicate that WTA precursor export is the rate-limiting step in the pathway, 
and TarG may also be more accessible to inhibitors than are most other WTA targets because 
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it spans the membrane. All identified TarG inhibitors suffer from a relatively high frequency 
of resistance (45; 233). Consequently, in an MRSA infection model, the TarG inhibitors were 
effective only in combination with β-lactams (233). It would be desirable to identify 
compounds with a lower frequency of resistance to validate late-stage enzymes as targets 
independent of β-lactams. 
 
1.9 Conclusion 
WTAs compose a huge percentage of the gram-positive cell wall and are thus 
extremely important for cell wall integrity. They are important for pathogenesis and play 
fundamental roles in bacterial physiology. Furthermore, their tailoring modifications 
modulate their structures and interactions with other molecules and cells in complex ways. 
The variety of enzyme classes involved in WTA biosynthesis (glycosyltransferases, 
polymerases, ABC transporters) and the diverse functions of WTAs make the ongoing study 
of this pathway challenging. Small-molecule inhibitors of WTA enzymes can be used to 
probe enzyme mechanism and WTA function in cells and to explore the potential of the 
different antibacterial target types.  
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Chapter 2: Construction and Analysis of a S. aureus mariner Transposon Library 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter are featured in “Genes contributing to Staphylococcus aureus success 
in infection-related ecologies” by Valentino, M.D., et. al. (2014) Submitted.   
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2.1 Abstract 
 Transposon libraries can facilitate large-scale reverse genetic experiments in many 
organisms.  When combined with high-throughput sequencing, these libraries can provide 
genome-wide phenotypic assessment at high resolution. In order to facilitate these studies in 
S. aureus, we needed to construct a high coverage transposon library. Here I describe the 
creation and initial characterization of this library, performed in collaboration with Dr. Ama 
Sadaka of the Gilmore lab. I also describe several statistical methods for the assessment of 
conditional gene essentiality. 
 
2.2 Introduction 
 Transposable elements (TEs) are DNA fragments that can move their chromosomal 
positions, either within or between genomes. They have been identified in all domains of life, 
in some cases comprising large fractions of an organism’s genetic material. Tes fall into two 
broad classes – retrotransposons (class I) function via an RNA intermediate, which is 
reverse-transcribed and inserted using enzymes encoded within the element. Class II 
transposons are DNA-based and are mobilized via a transposase. The required transposase is 
often encoded within the transposon, and surrounded by two terminal inverted repeats 
(TIRs), though some transposons are mobilized via enzymes supplied in trans or coopted 
from other transposons in the genome. TE insertion requires the activity of host DNA repair 
enzymes to fill in sequence gaps, generating unique target site duplications. Transposons can 
be further classified into superfamilies based on their sequence, TIRs, and target site 
duplications. 
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2.2.1 Superfamily Tc1/mariner 
 Tc1 and mariner superfamily members are the most widespread transposons and 
include some that have retained functionality. They are generally 1-5kb in length and are 
possess a transposase of 282-345 amino acids, with TIRs that are <100bp long (160). While 
the transposases of this superfamily diverge significantly in sequence similarity, they are all 
similarly organized into an N-terminal DNA/TIR binding domain, an intervening nuclear 
localization signal that promotes transposase entry into cell nuclei, and a C-terminal catalytic 
domain responsible for DNA cleaving and joining reactions. This catalytic domain possesses 
a characteristic DDD (or in the case of mariner, DDE) motif that was found to be 
functionally non-interchangeable with opposite superfamily members (143). 
 Members of the Tc1/mariner superfamily replicate through a cut-and-paste 
mechanism. First, monomers of the transposase bind each of the two TIRs flanking the 
transposon in single-end complexes. The transposase monomers then catalyze hydrolysis of 
the phosphodiester backbone at the 5’ termini flanking the transposon TIRs. Through a 
transposase dimerization, the two single-end complexes are brought together to form a 
paired-end complex, after which excision takes place via cleavage of the phosphodiester 
backbone at the 3’ ends. This leaves a double-stranded DNA break (DSB). The excised 
transposon, complexed with the transposase dimer, then mobilizes to a target location in the 
host genome – Tc1 and mariner transposons preferentially target TA dinucleotides. After 
insertion, transposon 5’ gaps are filled in, generating transposon-specific target site 
duplications, while the DSB at the transposons origin is filled in using host DNA repair 
enzymes, often generating a transposon footprint. 
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2.2.2 Effects of Transposon Mobilization  
Because of their dynamic nature, TEs can contribute to genetic organization, 
regulation, stability, and evolution (154; 186). The effects of their mobilization are most 
often mediated near their insertion location. Transposons can directly alter the expression of 
a gene by inserting within its exon/open reading frame, or they can indirectly alter expression 
by inserting in regulatory elements, such as promoters or terminators. TEs can also cause 
polar effects by inserting within polycistronic operons (124). These effects can be 
exacerbated in transposons containing transcriptional terminators or outward facing 
promoters (232). Nevertheless, transposons may also carry adjacent chromosomal regions 
during the processes of excision and insertion, promoting recombination events with distal 
regions of chromosomes. Through all of these mechanisms, transposons can alter the fitness 
of their host, in turn impacting their own probability of carriage.  
 A variety of host and TE regulatory mechanisms have evolved in order to mitigate the 
potentially deleterious effects of transposition. In order to maintain function, the ratio of TEs 
to their transposases must be carefully balanced and each must encode active versions – 
deviations in this ratio or mutations can lead to inhibition, potentially through the formation 
of inactive complexes or by diluting active subunits (133; 144). Some transposons, such as 
those encoding drug resistance factors, include regulatory elements that respond specifically 
to environmental cues to induce transposition (124). In eukaryotic hosts, epigenetic 
mechanisms, such as DNA methylation, or RNAi can suppress transposon activity (110; 
224). Furthermore, systems that detect and degrade foreign DNA, such as CRISPR and 
restriction-modification, can prevent TE horizontal transfer (28; 56; 148; 229).  
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2.2.3 Use of Transposon Mutagenesis to Determine Gene Essentiality in S. aureus 
   Given enough insertional coverage, the fitness cost of transposition into a locus can 
be used to assess gene essentiality across the genome. Saturating transposon mutagenesis has 
been used to assess the essentiality of genes in a variety of organisms, as a way to better 
understand physiology and identify strong candidates for interventional therapeutics. 
Transposon libraries can supersede the predictive power of comparative genomics in 
assessing the core genome, particularly for organisms with distant homology and encoded 
functional redundancies. Furthermore, transposon libraries can be grown in a variety of 
conditions, enabling rapid assessment of conditionally essential genes. 
   Bae et al. previously used the bursa aurealis mariner-based transposon system to 
generate a library in strain Newman consisting of approximately 8,400 mutants with defined 
unique insertion sites, which was screened for loss-of function mutants in a C. elegans 
infection model (15). Seventy-one genes responsible for virulence were identified, 
representing the first genome-wide query of genes critical for fitness in vivo (i.e. the C. 
elegans gut). While providing proof of principle, the library was reported to have disruptions 
in only 67% of all ORFs. More recently, Chaudhuri and colleagues utilized a modified E. coli 
Tn5-based transposon, coupled with microarray mapping and PCR-based verification, to 
identify genes that were intolerant of transposon insertion (47). A total of 351 genes were 
identified as incapable of being disrupted by transposon insertion and still yielding cells 
capable of growth in laboratory medium. Unfortunately, few Tn5 insertions were directly 
sequenced, so the actual level of genome saturation used in these experiments is unclear.  
 
2.2.4 Statistical Methods for Determining Gene Essentiality in Transposon Libraries 
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In principle, the absence of mapped transposons in a genomic locus corresponds to 
the inviability of insertional mutants. In reality, this could be attributed to several factors, 
including insertion bias, PCR jackpotting, and insufficient sensitivity of detection. Several 
studies have also noted that known essential genes can harbor insertions, but that these have a 
higher probability of appearing in the immediate 5’ and 3’ regions of an ORF, where they 
may preserve functional translation (2; 96). Early experimenters often excluded these 
extreme insertions from subsequent analyses, however more modern analytical methods can 
accommodate them by grouping them with insertions from adjacent regions. 
 Several statistical methods have been developed to determine gene essentiality from 
transposon insertion data in organisms with annotated genomes. Blades and Bowman used a 
Bayesian method called Gibbs sampling (a Markov Chain Monte Carlo algorithm) and 
Jacobs, et al. used parametric bootstrapping to estimate the total number of essential genes, 
assuming that transposon insertions followed a multinomial distribution (32; 115). A rigorous 
analysis of these approaches demonstrated that these methods required libraries with a large 
number of clones or accurate probabilistic models a priori for transposon insertions (243). 
Another approach utilizes likelihood ratio tests (e.g. D-values and ESSENTIALS (221; 258)). 
Others have modeled TA insertions as a Bernoulli process, where stretches of consecutive 
TA sites lacking insertions corroborate essentiality (96). This method had the advantage of 
finely tuning essentiality scores to provide insight on essential regions within an ORF, such 
as independently expressed protein domains. However, this model depended on a priori 
estimation of insertion frequency for non-essential genes, and was subsequently improved via 
more rigorous statistical methods, including Bayesian analysis with mixing and Hidden 
Markov modeling (62; 63). 
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2.2.5 Selection of a Transposon Delivery System for S. aureus 
 Screening or selection of mutagenized cell pools can facilitate the identification of 
genotypes pertaining to a phenotype or physiological process. Classical mutagenesis, often 
performed using chemical mutagens or radiation, must be carefully dosed to ensure single 
mutations in each cell. Alterations of the chromosome can then be identified through whole-
genome sequencing or complex mapping. In contrast, transposons traditionally enable finer 
dosage control and disruption stability, and through their known sequence, afford rapid 
identification of insertion loci via PCR. Furthermore, when combined with advances in DNA 
sequencing technologies, transposons enable massively parallel assays for mutant pools 
(223). These mutant pools can be prepared de novo, or characterized and arrayed into 
archived libraries for distribution. 
Several aspects of transposon and host were taken into consideration in selecting an 
appropriate transposon system for our genetic studies. We chose S. aureus HG003 as a 
methicillin-sensitive strain for the library, as this strain shares lineage with many other 
common laboratory strains (NCTC8325), is repaired in the tcaR and rsbU loci, and does not 
require the BL2+ safety precautions of methicillin-resistant brethren (108). Unlike RN4220, 
HG003 has been preserved from phage curing via successive rounds of UV-irradiation and 
chemical mutagenesis and has no defects in its restriction-modification system (161). While 
these characteristics help reduce artifacts introduced by laboratory handling, the presence of 
resident phage can lead to host heterogeneity due to spontaneous activation, and restriction 
requires passage of DNA first through a strain that installs modifications. This precluded the 
use of transposons assembled in vitro, such as EZ-Tn5 and Mu (170).  
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Historically, transposons such as Tn917 and Tn551, have proved useful in elucidating 
important aspects of Staphylococcal biology, but suffer from strong biases in insertion 
locations (15; 22). At the onset of our genetic studies, the Himar1-based system, bursa 
aurealis, appeared as the best candidate, due to its high efficiency of transposition and in vivo 
transposition approach (Figure 2.1) (15; 16; 47). The modified horn fly transposon contains 
an ermC erythromycin resistance gene, an R6K origin of replication, and a green 
fluorescence protein. This transposon is supplied on plasmid pBursa, which possesses the 
chloramphenicol selection marker cat and a S. aureus temperature-sensitive origin of 
replication. The transposase is supplied in trans under the xylose-inducible promoter xylA on 
plasmid pFA545, which contains the tetracycline resistance genes tetBD, the xylose 
repressor, xylR, and a temperature-sensitive origin of replication compatible with pBursa. 
Through mechanisms that remain elusive, temperature shift promotes transposon 
mobilization and plasmid curing, enabling selection of stable insertion mutants. This system 
was used to develop the Nebraska Transposon Mutant Library, a repository of 1,952 
transposon mutants in the community-acquired methicillin-resistant strain USA300 (82), and 
recent work by Bose, et al. has generated tools to exchange transposon mutants with 
alternative selection markers or fluorescent probes through allelic replacement (35). A phage-
based system has subsequently been developed that delivers pre-assembled Tn551 transposon 
cassettes at high efficiency without high temperature treatment or resident transposase-
expressing plasmids (232). This system is being improved further through continuing efforts 
in the Walker and Bernhardt laboratories. 
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Figure 2.1 Plasmids used for construction of a bursa aurealis transposon library. pBursa 
contains a modified Himar1 transposon, while pFA545 encodes the transposase in trans. 
Figure adapted directly from Bae & colleagues (16). 
 
2.3 Methods 
2.3.1 Bacterial Strains, Reagents, and General Methods  
Plasmids were introduced into restriction-negative S. aureus strain RN4220 by 
electroporation (142). To prepare electrocompetent cells, overnight cultures of S. aureus 
were diluted approximately 1:200 into media with tunicamycin and harvested in mid-
exponential phase. Cells were washed four times in 20mL of sterile 20% glycerol (v/v), 
before resuspension in approximately 600uL of sterile 20% glycerol and storage at -80°C. 
Plasmids were purified from S. aureus RN4220 by first washing cells with a 1:1 mixture of 
cold acetone:ethanol, then pretreating cells with lysostaphin (50 µg/ml, 10 min, 37°C) prior 
to isolation using a standard plasmid miniprep protocol (Qiagen). Plasmids were then 
introduced into restriction-positive wild-type strains by electroporation. S. aureus was grown 
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primarily in tryptic soy broth (TSB) medium at 30°C. Antibiotic markers were selected with 
erythromycin (Em) (10 µg/ml), tetracycline (Tet) (2.5 µg/mL), carbenicillin (Carb) 
(100µg/mL), and chloramphenicol (Cm) (5 µg/mL). Tunicamycin (Tm) purchased from 
Sigma Aldritch was dissolved in DMSO to a final concentration of 0.4µg/mL. Novagen KOD 
Hot Start Polymerase was used for inverse PCRs, restriction enzymes and T4 DNA ligase 
from New England Biolabs, terminal deoxynucleotidyl transferase (TdT) was purchased 
from Promega, and PCRs for Illumina sequencing were prepared using Easy A high-fidelity 
cloning enzyme from Agilent. Strains and oligonucleotides used for this work are listed in 
Table 2.1. 
 
Table 2.1: Bacterial strains, plasmids, and oligonucleotides used in this work. 
Strains Relevant Genotype Reference 
RN4220 RN450  partial agr defect ST8; CC8; 
codon in both hsdR and sauUSI 
 
(161) 
HG003 rsbU and tcaR repaired  NCTC 8325 2010 Herbert 
JSM060 HG003 pBursa pFA545 TetR CmR ErmR  
Plasmids Description Reference 
pBursa Mariner transposon plasmid, bursa aurealis, EmR, CmR, 
repTS 
(15) 
pFA545 Transposase plasmid, TetR, repTS (15) 
Oligonucleotide Sequence 
Martn-F 5′-TTTATGGTACCATTCATTTTCCTGCTTTTTC-3’ 
Martn-ermR 5′-AAACTGATTTTTAGTAAACAGTTGACGATATTC-3’ 
olj510 5’-CCAAAATCCGTTCCTTTTTCATAGTTCCTATATAGTTATACGC-3’ 
olj376 5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGGGGGGGGGGGGGGG-3’ 
olj511 5’-
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AATGATACGGCGACCACCGAGATCTACACTCTTTGACCGGGGACTTATCAGCCAACCTGTTA-3’ 
olj512 5’-ACACTCTTTGACCGGGGACTTATCAGCCAACCTGTTA-3’ 
BC1 5’-
CAGCAGAAGACGGCATACGAGATAAAAAAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC2 5’-
CAGCAGAAGACGGCATACGAGATACACACGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC3 5’-
CAGCAGAAGACGGCATACGAGATAGAGAGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC4 5’-
CAGCAGAAGACGGCATACGAGATATATATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC5 5’-
CAGCAGAAGACGGCATACGAGATCACACAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC6 5’-
CAGCAGAAGACGGCATACGAGATCCCCCCGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC7 5’-
CAGCAGAAGACGGCATACGAGATCGCGCGGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
BC8 5’-
CAGCAGAAGACGGCATACGAGATCTCTCTGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
3’ 
 
2.3.2 Construction of the bursa aurealis Transposon Library 
  S. aureus HG003 was electroporated sequentially with pFA545 and pBursa, then 
mutagenized using the bursa aurealis system as previously reported (15; 16; 108). 
Approximately 5,000 colonies from 20 plates were harvested directly using 5 mL BHI with 
Em to wash each plate, which was mixed with 5 mL 50% glycerol to generate 20 separate 10 
mL aliquots each representing a subset of the library. Before freezing at -80°C, each tube was 
thoroughly homogenized by vortexing and 1 mL was pooled into a single aliquot 
representing the entire library encompassing approximately 100,000 individual transposon 
insertions.  
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2.3.3 Library Analysis 
Genomic DNA was extracted using a Wizard Genomic DNA Preparation Kit. Initial 
analysis of insertions was performed using inverse PCR and sequencing per protocol (16). 
For complete characterization of the library, extracted DNA was sonicated, then a poly-C tail 
was addended using TdT. The reaction was purified using an EdgeBio PERFORMA column, 
then subjected to PCR with oligonucleotide primers olj510 and olj376. A small aliquot was 
then subjected to a second round of PCR using primer olj511 and one of the barcoding (BC) 
primers, and olj512 was provided for sequencing. Single-end Illumina sequencing was 
performed at the Tufts Genome Sequencing Facility. Reads were processed using the Galaxy 
Web Server (33; 92; 94). After sequences were clipped to remove the poly-C tail, filtered by 
quality (q = 7, p-95), and mapped with Bowtie to the NCTC 8325 genome. Mapped reads 
were assigned Dvals using the Tufts Med Galaxy Web Server AggCount algorithm. 
 
2.4 Results 
2.4.1 Characterization of the S. aureus HG003 mariner Library 
 We performed initial mobilization of the transposon library in small batches, in 
efforts to determine parameters for minimal clonal expansion, maximal diversity, and 
transposase plasmid curing. Inverse PCR and targeted sequencing for initial platings revealed 
diverse insertion sites (Figure 2.2, Table 2.2). A small fraction of mutants appeared to 
possess multiple insertions, as revealed by distinct transductants in unlinked loci originating 
from a single progenitor.  
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Figure 2.2: Inverse PCR for transposon insertions in 12 individual mutagenized S. aureus 
colonies. 
 
Table 2.2: Sample identified transposon insertion sites through targeted sequencing 
Genomic Site of 
Transposon Insertion 
NCTC 8325 ORF # Annotated Function 
1322640 SAOUHSC_01377 Oligopeptide transporter 
2323757 SAOUSHC_2519/2520 GNAT acetyltransferase or 
sugar transporter 
99539 SAOUHSC_00093 Superoxide dismutase 
152720 SAOUHSC_00144 Aureolysin NRPS 
1531492 SAOUHSC_01606 Peptidase T 
213259 SAOUHSC_00192 Coagulase 
649578 SAOUHSC_00661 Lipase/hydrolase 
2657937 SAOUHSC_02885 PG acetyltransferase OatA 
 
 While inverse PCR afforded accurate identification of transposon insertion sites, this 
technique was recalcitrant toward scale-up and analysis of pooled mutants. Previous studies 
employed signature tagging (e.g. Signature Tagged Mutagenesis, STM (106)) and 
microarray-based approaches (e.g. Transposon Site Hybridization, TraSH (193), and 
Genomic Array Footprinting, GAF (30)), but these may lead to ambiguous assignment of 
transposon location through cross-hybridization and poor resolution. Modern techniques, 
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such as Tn-Seq/InSeq and TraDIS (95; 135; 222) can exploit the higher sensitivity and 
throughput afforded by next-generation sequencing.  
In order to obtain detailed information about library composition, we sent library 
samples to the Tufts University Genomics Core Facility, where they were analyzed using 
50bp single-end reads on an Illumina HiSeq 2500. Raw reads were trimmed and mapped 
onto the NCTC 8325 genome. A large number of sequencing reads were successfully 
mapped to diverse loci (Figure 2.3, Table 2.3). A total of 72,699 unique insertion sites were 
detected in 6,246,137 PCR reads with 80% in genic regions – this approaches the 85% of the 
total chromosome occupied by genes. For the S. aureus genome, this represents coverage of 
24X, higher than all other reported libraries, providing an average of 1 insertion per 38.8 base 
pairs (15; 19; 47; 139; 156). A second assessment of the library, grown for 24 hours in BHI 
media after dilution from an overnight starter culture, showed a moderate decrease (16%) in 
the number of genic insertion sites, despite a higher proportion of mapped reads. This 
suggested that a number of initially identified transposon mutants were either inviable, 
susceptible to freeze-thawing of the library, or highly compromised for growth and 
outcompeted by other library members. For both data sets, approximately equal numbers of 
insertions were identified on each strand of the chromosome. Out of 2969 total ORFs, 339 
lacked transposon insertions (345 for the sample post-24 hours growth). The ORF with the 
largest number of unique insertions (550 in the initial, 391 post-outgrowth) was ebhB, though 
at 28.6kb this is the largest gene on the chromosome.  Normalizing for gene size, the ORF 
with the largest number of unique insertions was SAOUHSC_00636, annotated as an ABC 
transporter for chelated iron. As observed in other organisms, a greater number of sequenced 
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insertions were identified near the chromosomal origin in comparison to the terminus (Figure 
2.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Mapped transposon insertions across the NCTC 8325 genome. Genes on the 
forward strand are denoted in red, and those on the reverse strand are denoted in blue, while 
Table 2.3 Transposon Library Sample Reads 
 
Initial 
Library +24 hrs 
Total Insertion Sites 72,699 61,061 
Total Genic Insertion Sites 57,825 48,317 
Total Intergenic Insertion Sites 14,874 12,744 
Total Reads 6,246,137 10,497,679 
Total +Strand 3,139,416 4,880,073 
Total -Strand 3,106,721 5,617,606 
Total Genic Reads 5,051,212 8,239,326 
Total Intergenic Reads 1,194,925 2,258,353 
Genome Size 2,821,361  
Genic Regions 2,397,907  
Intergenic Regions 423,454  
Total TA Sites 269,582  
Total ORFs 
 
2969  
Calculated Coverage 24.49 20.57 
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insertions are denoted in pink above (outermost circle) and below (innermost circle) for each 
strand. 
 
Figure 2.4 Plots of identified insertions based on chromosome position reveal an uneven 
distribution with bias toward the chromosomal origin of replication. 
 
2.4.2. Statistical Analysis of Essential Genes in the Transposon Library 
  The first approach that we used in order to quantitatively analyze our insertional data 
was to calculate a Dval. Each gene’s Dval represents the observed number of mappable reads 
of insertions in a gene, divided by the number of mappable reads of insertions predicted for a 
gene based on its size relative to the genome and the total number of mappable reads 
obtained for that experiment. Thus, Dval is normalized the total number of insertion 
amplicon reads occurring in a specific gene to the number expected for that gene bases solely 
on its size and assuming complete randomness of insertion. For example, in our library, the 
gene dnaA encoding DNA replication initiation protein has a length of 1361 bp, in a genome 
of size 2,821,361bp. If one assumed that the reads obtained were equally distributed across 
the genome, then the expected number of insertions within dnaA is 0.048% of the total 
number of reads (6246137) or 2994 reads. We observed only 48 reads in dnaA, a Dval of 
.016, suggesting transposon mutants in this gene are underrepresented in the library. Dvals 
>1 suggest that transposon mutants are overrepresented within a given gene. For example, 
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SAOUSHC_00636 had Dval >100, with ~6% of the total reads. In addition to the 339 ORFs 
lacking transposons entirely, 13 possessed Dvals ≤ 0.01 strongly suggesting their essentiality. 
Approximately 70 more genes possessed Dvals ≤0.10 but > 0.01 and several of these were 
manually curated for essentiality based on their possession of transposons insertions at 
densities below 0.00285 (1 insertion every 350bp, approximately 1/10 the expected insertion 
frequency). This overall number of essential genes (approximately 420) is in accord with 
several literature studies, though somewhat higher than observed for bacteria such as E. coli 
and M. tuberculosis. We categorized multiple genes as nonessential that have been 
previously reported as essential and vice-versa (Table 2.4) (47). In some cases, such as for 
fructose bisphosphate aldolase, the identified insertions were all outside of a protein domain 
or active site, suggesting that these mutants retained gene function and are false negatives for 
essentiality. Estimation of the number of essential genes using a Hidden Markov Model gave 
982 essential genes, which reduced to 681 in subsequent samples with higher coverage 
(Table 2.5). We hypothesize that the tendency of the HMM method to predict a higher 
number of essential genes is due to sampling only about one quarter of the total genomic TA 
sites, which is lower saturation than the transposon libraries for which this algorithm was 
initially developed. 
Table 2.4: Genes With Different Essentiality Than Reported In Vitro 
Gene Our Finding ProteinID Length 
SAOUHSC_00003 Essential Hypothetical protein 245 
SAOUSHC_00345 Essential Hypothetical protein 203 
secE Essential preprotein translocase subunit 182 
SAOUSHC_00884 Essential 
Putative monovalent cation/H+ antiporter 
subunit F 293 
SAOUHSC_00887 Essential 
Putative monovalent cation/H+ antiporter 
subunit C 329 
SAOUHSC_00892 Essential Hypothetical protein 344 
SAOUHSC_01721 Essential Hypothetical protein 260 
SAOUHSC_A01041 Nonessential Hypothetical protein 224 
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SAOUHSC_02805 Nonessential Hypothetical protein 302 
SAOUHSC_02575 Nonessential Hypothetical protein 422 
SAOUHSC_02366 Nonessential Fructose-bisphosphate aldolase 860 
SAOUHSC_01979 Nonessential Hypothetical protein 464 
SAOUHSC_01782 Nonessential Hypothetical protein 608 
SAOUHSC_00998 Nonessential FmtA 1193 
SAOUHSC_00760 Nonessential Hypothetical protein 1070 
    
Table 2.5 Hidden Markov Model for Transposon Library 
Category Total Avg. Insertions Avg. Reads 
Essential 681 0.06 172.6 
Growth Depleted 431 0.103 210.8 
Nonessential 1759 0.178 324.3 
Growth Advantage 0 0 0 
 
2.5 Conclusion 
 Using the bursa aurealis system, we constructed a highly saturated transposon library 
in S. aureus HG003. By employing TnSeq, we were able to accurately map the locations of 
transposon insertions to positions in the genome. Using several different statistical methods, 
we were then able to predict the likelihood of gene essentiality based on the presence or 
absence of PCR reads from a genomic locus. Together, these tools enabled us to determine 
the conditional essentiality of genes upon treatment of the library with tunicamycin to deplete 
wall teichoic acids from the population.  
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Chapter 3: A Chemical Genetic Strategy to Map Interactions with Wall Teichoic Acids 
in Staphylococcus aureus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The majority of this chapter is included in the article “Compound-gene interaction mapping 
reveals distinct roles for Staphylococcus aureus teichoic acids” by Santa Maria Jr., J.P., et al. 
(2014) Submitted. 
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3.1 Abstract 
The bacterial cell envelope was historically viewed as a protective barrier that enables 
survival in challenging environments, but recent evidence shows that envelope constituents 
also play roles in physiological processes such as cell division. In Staphylococcus aureus, 
deletion of either lipoteichoic (LTA) or wall teichoic acid (WTA) polymers results in 
doubled and misoriented septa as well as impaired cell separation. To gain insight into TA 
function, we employed a small molecule inhibitor to screen a highly saturated transposon 
library for cellular factors that become essential when WTAs are depleted. Based on the 
results and follow up validation we constructed a network connecting WTAs with genes 
involved in LTA synthesis, peptidoglycan synthesis, surface protein display, and D-alanine 
cell envelope modifications. Unexpectedly, D-alanylation, a shared modification of LTAs 
and WTAs, became essential in the absence of WTAs, but not LTAs. 	  
 3.2 Introduction  
Bacteria are surrounded by a complex cell envelope that performs many different 
functions important for survival. In Gram-positive organisms such as Staphylococcus aureus, 
the major components of the cell envelope are peptidoglycan (PG) and teichoic acids (Figure  
3.1). PG, a polymer of highly crosslinked carbohydrate chains that encapsulates the cell, is a 
well-established target for clinically useful antibiotics, due to its essential role in providing 
structural support and protection from osmotic lysis. S. aureus teichoic acids are anionic 
polymers of two main types: lipoteichoic acids (LTAs), which are embedded in the cell 
membrane and comprise a poly(glycerolphosphate) backbone tailored with D-alanine esters, 
and wall teichoic acids (WTAs), which are covalently attached to PG and possess a 
poly(ribitolphosphate) backbone functionalized with D-alanine and N-acetylglucosamine 
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(GlcNAc) moieties (41; 189). Unlike PG, LTAs and WTAs are individually dispensable for 
survival in vitro, but they play critical roles in pathogenesis (168; 237). Moreover, strains 
lacking either TA polymer have severe septal defects and compromised fitness even in vitro, 
implying that these pathways are also possible targets for antibiotics (44; 46; 168; 173; 199; 
200). Efforts to make strains lacking both LTA and WTA polymers have not been successful, 
suggesting that simultaneous inactivation of the two pathways is lethal (168; 198). While 
their importance is readily apparent, TAs are still not well understood. LTAs and WTAs are 
thought to play partially redundant roles in S. aureus cell division and envelope integrity, and 
this view is bolstered by the fact that the same D-alanylation machinery is used to install D-
alanine esters on both polymers (166). It has been difficult to identify unique roles for the 
two polymers through phenotypic analysis because deletion has pleiotropic effects and the 
observed phenotypes are similar. We reasoned that more insight into distinct functions of 
LTAs and WTAs could be gleaned by identifying the genes that become essential when 
either polymer is removed. Therefore, we carried out an unbiased screen for cellular factors 
that become essential when WTAs are absent. Based on the screen and a set of targeted gene 
deletions, we have constructed an interaction network for WTAs. Here we describe the 
screen, our follow up validation, the interaction network, and results showing that many 
genes that become essential in the absence of WTAs are dispensable when LTAs are deleted. 
For example, D-alanylation becomes an essential modification of LTAs when WTAs are not 
made; however, it is not required on WTAs when LTAs are deleted. We conclude that WTAs 
and LTAs act as part of distinct networks. 
	  	   52	  
 
Figure 3.1: Teichoic acids are a major component of the S. aureus cell envelope. WTAs are 
attached to PG, while LTAs are linked to membrane-bound lipid carriers (diacylglycerol, 
DAG). Tunicamycin is a selective inhibitor of the first step of WTA biosynthesis, catalyzed 
by TarO(44; 181; 234)}. 
 
3.3 Methods 
3.3.1 Bacterial Strains, Reagents, and General Methods 
Plasmids were constructed in Escherichia coli XL-1 Blue (Stratagene) or Stellar Gold 
(Clontech) competent cells and introduced into restriction-negative S. aureus strain RN4220 
by electroporation(194). Plasmids were purified from S. aureus RN4220 by first washing 
cells with a 1:1 mixture of cold acetone:ethanol, then pretreating cells with lysostaphin (50 
µg/ml, 10 min, 37°C) prior to isolation using a standard plasmid miniprep protocol (Qiagen). 
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Plasmids were then introduced into restriction-positive wild-type strains by electroporation. 
S. aureus was grown primarily in tryptic soy broth (TSB) medium at 30°C. Antibiotic 
markers were selected with erythromycin (Em) (10 µg/ml), tetracycline (Tet) (2.5 µg/mL), 
carbenicillin (Carb) (100µg/mL), a combination of kanamycin and neomycin (Km) 
(50µg/mL, each) and chloramphenicol (Cm) (10 µg/mL). Tunicamycin (Tm) purchased from 
Sigma Aldritch was dissolved in DMSO and diluted to a final concentration of 0.4µg/mL.  
Anhydrotetracycline was dissolved in 100% ethanol to a 1000X stock of 100µg/mL. 
Novagen KOD Hot Start Polymerase was used for all PCRs and all restriction enzymes were 
purchased from New England Biolabs. A Clontech In-Fusion HD Cloning Kit was used for 
isothermal assembly.   
3.3.2 Transposon Library and Screen 
The transposon library was constructed in S. aureus HG003 using the bursa aurealis 
system(15). Frozen aliquots of the library stock were thawed and diluted 1:1000 into 10 mL 
of BHI overnight at 37°C. This culture was then diluted 1:100 into 100mL of BHI with or 
without Tm, then grown at 37°C for 24 hours. Cells were pelleted and DNA was extracted 
using a Wizard Genomic DNA Preparation Kit. The DNA was sheared, addended with a 
polyC tail (TdT, Promega), amplified and barcoded via PCR, and sequenced using an 
Illumina Hi-Seq2000 at the Tufts Genome Sequencing Facility. Insertions were mapped to 
ORFs using the sequenced NCTC 8325 genome and the Galaxy webserver. The Mann-
Whitney-U Test was used in combination with Fisher’s Test to identify mutants in genes for 
which tunicamycin treatment led to significant depletion as compared to the number of 
identified reads for the untreated control. 
3.3.3 Construction of Mutant Strains 
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Gene deletions were made using the pMAD and pKFC allelic replacement 
systems(10; 120). For plasmids pMADvraFG (P1-P4), pKFClyrA (P5-P8), pKFC965 (P9-
P12), flanking arms with homology to chromosomal regions adjacent to the deletion locus 
were obtained via PCR. Arms were then digested and ligated together and amplified again 
using PCR, or spliced via overlap PCR with upFor and downRev primers, then digested, gel 
purified, and ligated into digested parent vector. Double crossovers were performed at 39-
40.5°C and validated as TmS and EmS (pMAD) or TmS and CmS (pKFC) by restreaking in the 
presence and absence of these antibiotics overnight, then confirmed via sequencing. Plasmids 
pKFCgraR (P13-P16), pKFCtarOlink (P17-P20), pKFCdltD (P21-P24), pKFClyrAkan (P39-
P42), and pKFC965kan (P43-P46) were instead assembled from flanking homology arms 
with an intervening antibiotic marker (aphA3 P25-P26, tetM P27-P28) using isothermal 
assembly. Double crossovers were validated as TmS CmS TcR or TmS CmS KmR via 
restreaking and sequencing. Strain JSM061 was obtained via pMADdltA, in a manner similar 
to MW2 ΔdltA(42). Strains JSM069 and JSM061 were obtained via phage transduction of 
marked deletions into clean background strains. Complementation constructs pLOWgraR 
(P29-P30), pLOWvraFG (P31-P32), pLOWlyrA (P33-P34), pLOW965 (P35-P36), and 
pLOWDlt (P37-P38) were cloned into pLOW via restriction digest and ligation, using 
primers listed in Table 2 (141). Double mutant strains, used to construct the pathway 
interaction map (Figure 3.4) were created through ϕ85 transduction of a marked deletion into 
unmarked deletion backgrounds. 
3.3.4 Linkage Analysis 
Strain JSM095 was created by installing a aphA3 (KmR) marker approximately 4.5kb 
downstream of ΔtarO::tetR in TCM011 using pKCtarOlink. Donor phage ϕ85 was prepared 
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from this strain and used to transduce aphA3 into WT and mutant backgrounds. KmR 
colonies were obtained at 37°C, then assayed for TetR and Congo Red sensitivity in 96-well 
format, overnight at 37°C(208). 
Table 3.1: Strains used in this study 
Strains Relevant Genotype Reference or 
Source 
RN4220 RN450 partial agr defect ST8; CC8; 
codon in both hsdR and sauUSI 
(129) 
Newman ST8; CC8 isolated in 1952 human clinical MSSA (69) 
HG003 rsbU and tcaR repaired NCTC 8325 (108) 
MW2 
(USA400) 
Clinical isolate; community-acquired methicillin 
resistant (CA-MRSA) 
(12) 
MW2 ΔdltA  
 
 
(42) 
RN6911 Δagr::tetM derivative of RN6390 
 
 
(167) 
TCM011 ΔtarO::tetR pCL25 Ppen tarO TetREmR Laboratory 
Stock 
SEJ1 RN4220Δspa (100) 
4S5 SEJ1ΔltaS suppressor strain (55) 
LAC* CA-MRSA LAC strain (AH1263) (34) 
ANG2134 LAC*ΔltaSN::erm, EmR (55) 
ANG2570 LAC* ΔgdpP::kanR pCL55iTETr862-gdpP, KmR, CmR (54) 
ANG1838 4S5 pCN34iTET-gdpP4S5 (55) 
JSM060 HG003 pBursa pFA545 CmR EmR TetR This Study 
JSM065 Newman [ΔgraR::tetM] by transduction, TetR This Study 
JSM084 Newman pLOWgraR, EmR This Study 
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JSM081 JSM065 [ΔgraR::tetM] by transduction, TetR, EmR This Study 
JSM061 RN4220 ΔvraFG This Study 
JSM111 RN4220 pLOWvraFG EmR This Study 
JSM085 JSM061 pLOWvraFG EmR This Study 
JSM064 Newman ΔdltA This Study 
JSM063 Newman ΔdltD::aphA3, KmR This Study 
JSM095 TCM011 aphA3, KmR TcR EmR This Study 
JSM073 SM002 [ΔdltD::aphA3] by transduction KmR This Study 
JSM074 SM003 [ΔdltD::aphA3] by transduction KmR This Study 
JSM071 JSM064 [ΔlyrA::aphA3] by transduction KmR This Study 
JSM072 JSM064 [ΔSAOUHSC_00965::aphA3] by transduction 
KmR 
This Study 
JSM090 4S5 [ΔdltD::aphA3] by transduction KmR This Study 
JSM104 4S5 [ΔSAOUHSC_00965::aphA3] by transduction KmR This Study 
JSM103 4S5 [ΔlyrA::aphA3] by transduction KmR This Study 
JSM067 JSM061 [ΔdltD::aphA3] by transduction KmR This Study 
JSM096 JSM061 [ΔlyrA::aphA3] by transduction KmR This Study 
JSM097 JSM061 [ΔSAOUHSC_00965::aphA3] by transduction 
KmR 
This Study 
JSM098 SH002 [ΔgraR::tetM] by transduction, TcR  This Study 
JSM099 SH003 [ΔgraR::tetM] by transduction, TcR This Study 
JSM072 JSM065 [ΔdltD::aphA3] by transduction TcR KmR This Study 
JSM132 RN4220 pLOWDlt EmR This Study 
JSM137 JSM061 pLOWDlt EmR This Study 
JSM133 Newman pLOWDlt EmR This Study 
JSM136 JSM065 pLOWDlt EmRTcR This Study 
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JSM135 4S5 pLOWDlt EmR This Study 
JSM159 SEJ1 [ΔgdpP::kanR] by transduction, KmR This Study 
SHM002 HG003 ΔlyrA This Study 
SHM009 SM001 pLOWlyrA EmR This Study 
SHM003 HG003 ΔSAOUHSC_00965 This Study 
SHM010 SM003 pLOW965 EmR This Study 
SHM037 HG003 ΔlyrA::aphA3 KmR This Study 
SHM039 HG003 ΔSAOUHSC_00965::aphA3 KmR This Study 
SHM086 JSM064 pLOWDlt EmR This Study 
SHM091 JSM061 pLOWDlt EmRKmR This Study 
SHM094 SM002 pLOWDlt EmR This Study 
SHM095 SM003 pLOWDlt EmR This Study 
 
Table 3.2: Plasmids and oligonucleotide primers used in this study 
Plasmid or 
Primer 
Description or Sequence Referen
ce or 
Source 
Plasmids  
 
 
 
pBursa Mariner transposon plasmid, bursa aurealis, EmR, repTS, CmR (15) 
pFA545 Transposase Plasmid TcRrepTS (15) 
pMAD E. coli/S. aureus shuttle vector oriTs X-Gal colorimetric selection 
CarbR EmR 
(10) 
pKFC Temperature-sensitive shuttle vector; oriTs CarbRCmR (120) 
pLOW Low-copy expression plasmid CarbREmR (141) 
pTM378  Template for aphA-3 gene, KmR (232) 
pCL55iTETr
862-gdpP 
Integrative plasmid with gdpP under an anhydrotetracycline-
inducible promoter, CmR 
(54) 
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pMADvraFG P1-P4 PCR in pMAD for deletion of vraFG CarbREmR This 
Study 
pKFCgraR P13-P16 PCR in pKFC for replacement of graR with tetM 
CarbRTcR CmR 
This 
Study 
pKFCdltD P21-P24 PCR in pKFC for replacement of dltD with aphA-3 
CarbRKmR CmR 
This 
Study 
pKFClyrA P5-P8 PCR in pKFC for markerless deletion of lyrA CarbRCmR This 
Study 
pKFClyrAka
n 
P39-P42 PCR in pKFC for replacement of lyrA with aphA-3 
CarbRKmR CmR 
This 
Study 
pKFC965 P9-P12 PCR in pKFC for markerless deletion of lyrA CarbRCmR This 
Study 
pKFC965kan P43-P46 PCR in pKFC for replacement of 965 with aphA-3 
CarbRKmR CmR 
This 
Study 
pLOWvraFG P31-P32 PCR in pLOW for expression VraFG CarbREmR This 
Study 
pLOWgraR P29-P30 PCR in pLOW for expression of GraR CarbREmR This 
Study 
pLOWlyrA P33-P34 in pLOW for expression of LyrA CarbREmR This 
Study 
pLOW965 P35-P36 in pLOW for expression of 965 CarbREmR This 
Study 
pLOWDlt P37-P38 in pLOW for expression vector of DltABCD CarbREmR This 
Study 
pKFCtarOlin
k 
P17-P20 PCR in pKFC for installation of aphA-3 4.3kbp 
downstream of tarO::tetR CarbRKmR CmR 
This 
Study 
Primers  
 
 
 
P1. vraFG 
EcoRI upFor 
taGAATTCaactcgatgctagatacaca  
 
 
P2. vraFG 
XhoI upRev 
taCTCGAGttaacactcctataatttatctt  
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P3. vraFG 
XhoI 
downFor 
taCTCGAGacgagataatatttaaaaatttcc  
 
 
P4. vraFG 
BamHI 
downRev 
taGGATCCaataaaataaacataagtgtac  
 
 
P5. lyrA 
BamHI upFor 
gatctgattGGATCCaatattgagcatacgcaatatc  
 
 
P6. lyrA 
upRev 
ctagcaagcgctttgtatatgtaacctccattag  
 
 
P7. lyrA 
downFor 
ctaatggaggttacatatacaaagcgcttgctag  
 
 
P8. lyrA SalI 
downRev 
gatctgattGTCGACcatgacgctgggaattgg  
 
 
P9. 965 
BamHI upFor 
gatctgattGGATCCtcagtgaatttttggaaattg  
 
 
P10. 965 
upRev 
cgtctaagaaaagcttattataacttaccttcttattc  
 
 
P11. 965 
downFor 
gaataagaaggtaagttataataagcttttcttagacg  
 
 
P12. 965 SalI 
downRev 
gatctgattGTCGACaagttatattaatatatgaacttc  
 
 
P13. graR 
upFor 
GACGGCCAGTGAATTcgaacaggttgttgc  
 
 
P14. graR 
upRev 
gcgagatttgggttgttcaataccagcaac  
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P15. graR 
downFor 
gttatataaatatggcgtttcgagagatac  
 
 
P16. graR 
downRev 
CGACTCTAGAGGATCatacctaattgatcc  
 
 
P17. tarO 
link upFor 
GACGGCCAGTGAATTCctggcagatgaaaatccatt  
 
 
P18. tarO 
link upRev 
acctcaaatggttcgctttacgattttcgactcgga  
 
 
P19. tarO 
link downFor 
gttttagtacctaggggaagtataattgcgtattga  
 
 
P20. tarO 
link 
downRev 
CGACTCTAGAGGATCtctgttaaatgtacagctttc  
 
 
P21. dltD 
upFor 
GACGGCCAGTGAattcttcccaacgatttcat  
 
 
P22. dltD 
upRev 
acctcaaatggttcgccgtaactcttctaatgcttca  
 
 
P23. dltD 
downFor 
gttttagtacctaggaatacaaatagcacataactca  
 
 
P24. dltD 
downRev 
CGACTCTAGAGGATCtcataatggttaaaattaaaaagc  
 
 
P25. aphA-3 
for 
gcgaaccatttgaggtgat  
 
 
P26. aphA-3 
rev 
cctaggtactaaaacaattcat  
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P27. TetM for caacccaaatctcgcaatttg  
 
 
P28. TetM 
rev 
ccatatttatataacaacataaaacgc  
 
 
P29. pLOW 
graR SalI For 
taGTCGACagaaaatatgaaatatactaaatg  
 
 
P30. pLOW 
graR XmaI 
Rev 
taCCCGGGttattcatgagccatatatcc  
 
 
P31. pLOW 
vraFG SalI 
For 
taGTCGACtaaattatagga gtgttaaagtg  
 
 
P32. pLOW 
vraFG XmaI 
Rev 
taCCCGGGttatatggaatgtctaattgttc  
 
 
P33.pLOW 
lyrA For 
gattGTCGACgttacctaatggagg  
 
 
P34. pLOW 
lyrA Rev 
ttaaGGATCCttattaatggtgatggtgatggtgtttgtttttatctgaagattgttc  
 
 
P35. pLOW 
965 For 
gattGTCGACgttgaataagaaggtaag  
 
 
P36. pLOW 
965 Rev 
gattGGATCCttaagcattaaaaattaataacaatataatagctac  
 
 
P37. pLOW 
Dlt For 
gattGTCGACtgagttctaatgagggag  
 
P38. pLOW 
Dlt Rev 
ttaaGGATCCttaatttttaggtttatctacttc  
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P39. lyrAkan 
upFor 
CCTAATGGAGGTTACATATAGCGAACCATTTGAGGTGAT
AGG 
 
 
P40. lyrAkan 
upRev 
CCTATCACCTCAAATGGTTCGCTATATGTAACCTCCATTA
GG 
 
 
P41. lyrAkan 
downFor 
GATGAATTGTTTTAGTACCTAGGACAAAGCGCTTGCTAG
TACCTC 
 
 
P42. lyrAkan 
downRev 
GAGGTACTAGCAAGCGCTTTGTCCTAGGTACTAAAACAA
TTCATC 
 
 
P43. 965kan 
upFor 
GATTGTTGAATAAGAAGGTAAGTTATAGCGAACCATTTG
AGGTGATAGG 
 
 
P44. 965kan 
upRev 
CCTATCACCTCAAATGGTTCGCTATAACTTACCTTCTTAT
TCAACAATC 
 
 
P45. 965kan 
downFor 
GATGAATTGTTTTAGTACCTAGGAATAAGCTTTTCTTAG
ACGTATGTG 
 
 
P46. 965kan 
downRev 
CACATACGTCTAAGAAAAGCTTATTCCTAGGTACTAAAA
CAATTCATC 
 
 
 
 
3.4 Results 
3.4.1 Design of an Unbiased Screen for Cellular Factors that Interact with WTAs 
To understand TA function better, we sought to design a genome-wide synthetic 
lethal screen for factors that interact with WTAs. Transposon mutagenesis is the standard 
way to generate a diverse mutant collection for genome-wide interrogations, but it is not 
possible to construct a transposon library in a WTA-deficient strain because bacteria lacking 
WTAs are temperature-sensitive as well as phage-resistant, which makes them recalcitrant to 
available techniques for making transposon mutant libraries(15; 46; 225; 232). In principle, it 
is possible to overcome this issue by constructing the transposon library in a wildtype strain 
and then using an inhibitor to turn off WTA expression. We have previously shown that the 
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natural product tunicamycin is a potent and highly selective inhibitor of S. aureus TarO, the 
first enzyme in the WTA pathway (Figure 3.1) (44; 181; 234). To use tunicamycin to 
comprehensively probe the S. aureus genome for interactions with WTAs, we needed a 
highly saturated transposon mutant library. Using a mariner-based transposon system(15), 
we constructed a mutant pool in S. aureus HG003(108). Transposon-directed insertion site 
sequencing (TraDIS), a PCR-based next generation sequencing technique that determines the 
location and abundance of transposon insertions in a population, showed that the library 
contained 60,000 independent insertion sites (Figure 3.2), which represents approximately 
twenty-fold coverage of the S. aureus genome (135; 221; 223). The high saturation of the 
transposon library enabled us to screen for genes that interact with WTAs by using 
tunicamycin to turn off WTA synthesis.  
 
Figure 3.2: The transposon screen identified 24 genes that are synthetically lethal with WTA 
depletion. (A) Schematic showing how genes that become essential (purple) with WTA 
depletion (i.e., TarO inhibition) are identified by comparing the reads for tunicamycin-treated 
and untreated transposon libraries. (B) Correlation between replicates of the tunicamycin-
treated transposon library. Blue diamonds represent each of the 2969 ORFs assessed. 
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3.4.2 Identification of Transposon Mutants Sensitive to WTA Depletion 
We grew replicate cultures of the pooled mutant library in the presence and absence 
of tunicamycin, sequenced the transposon insertion sites, and quantified PCR reads for each 
transposon mutant under each condition (Figure 3.2A, Supplementary File 1). Replicates of 
tunicamycin treatment strongly correlated in PCR reads for each ORF (Figure 3.2B). As 
shown in Table 3.3 and Figure 3.3, a similar number of reads were obtained for both treated 
conditions, yet we observed a significant reduction in the total number of insertion sites 
(average of 10.74% reduction after normalization). Genic insertion sites were 
disproportionately reduced in comparison to intergenic sites (11.31% vs. 8.9% normalized). 
This suggested that several mutants had been eliminated from the population, i.e. were 
synthetically lethal with WTA depletion. 
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Figure 3.3: Transposon insertion map for both overnight (innermost pink circle) and 
tunicamycin treatments (replicate 1, middle pink circle, replicate 2, outermost pink circle). 
 
Table	  3.3:	  Transposon	  Library	  Statistics	  
	   	  
	   	  
Initial	  
Library	  
No	  Tun	  
(24hrs)	  
Tun1	  	  
(24	  hours)	  
Tun2	  (24	  
hours)	  
Total Insertion Sites 72699 61061 56829 52516 
Total Genic Insertion Sites 57825 48317 44698 41276 
Total Intergenic Insertion 
Sites 14874 12744 12131 11240 
Total Reads 6246137 10497679 11569611 9598001 
Total +Strand 3139416 4880073 5914259 4865991 
Total -Strand 3106721 5617606 5655352 4732010 
Total Genic Reads 5051212 8239326 8990388 7424194 
Total Intergenic Reads 1194925 2258353 2579223 2173807 
Genome Size 2,821,361 
   Genic Regions 2,397,907 
   Intergenic Regions 423,454 
   Total ORFs 
 
2969 
   Calculated Coverage 24.5 20.6	   19.1	   17.7	  
 
The differences in PCR reads (normalized by total reads obtained) between the two 
conditions, expressed as growth ratios, were assigned statistical significance based on the 
coverage of transposon insertions within the boundaries of a particular ORF (Mann-Whitney 
U test). Using this method, we were able to assess mutants in 2,535 ORFs (85% of the 
genome) for differential growth. We favored this analysis over calculating the Dval ratio 
between treatment and no drug control, as this method tends to generate false positives more 
for ORFs highly depleted from the no treatment condition. Nevertheless, each method of 
anlaysis yielded partially-overlapping results (Table 3.4). Fewer than 49 ORFs showed a 
difference in growth upon tunicamycin treatment (p<0.05), and of these 2 were enriched and 
47 were depleted from the population. To identify genes that were synthetically lethal with 
WTA deletion, we established a stringent cut-off of >90% growth depletion in tunicamycin 
with a p value of <0.002. Only ten genes met these criteria (Fig. 3.3A). Decreasing the 
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stringency of the cutoff to 85% growth depletion with p<0.04 yielded fourteen additional 
genes (Figure 3.3B). Hence, a very small subset of approximately 2,500 disrupted genes in 
the mutant library showed a strong synthetic phenotype with WTA depletion. Notably, the 
majority of the genes in the list of 24, including eight of the top ten genes, were predicted to 
localize to the membrane or to have a cell envelope-related function. Because WTAs reside 
in the cell envelope, one would expect their synthetic lethal interactions to be weighted 
towards factors that contribute to envelope biogenesis and integrity.  
 
Figure 3.3: (A) The 10 most depleted genes are plotted by -log p values; the area of the 
circles reflects the extent of growth depletion, with the smallest circles denoting ~90% 
depletion. (B) Extended list of 24 genes with p<0.04 and >85% depleted from the transposon 
pool.   
Table 3.4: Top Genes >300bp Long with Dval Ratios < 0.10 Upon Tunicamycin Treatment 
Gene DvalRatio ProteinID Length 
SAOUHSC_00452 0.00 hypothetical protein 329 
msrR 0.00 transcriptional regulator 983 
	  	   67	  
dnaJ 0.00 chaperone protein DnaJ 1139 
SAOUHSC_02153 0.00 hypothetical protein 680 
atpI 0.00 hypothetical protein 452 
yyaA 0.00 hypothetical protein 839 
SAOUHSC_00965* 0.00 hypothetical protein 602 
vraF 0.00 ABC transporter ATP-binding protein 761 
Pnp 0.00 polynucleotide phosphorylase/polyadenylase 2096 
SAOUHSC_02316 0.01 DEAD-box ATP dependent DNA helicase 1520 
graR 0.01 hypothetical protein 674 
SAOUHSC_02406 0.01 hypothetical protein 932 
SAOUHSC_00618 0.01 hypothetical protein 716 
vraG 0.01 ABC transporter permease 1889 
SAOUHSC_01050 0.01 hypothetical protein 1019 
SAOUHSC_02001 0.02 hypothetical protein 1043 
SAOUHSC_01472 0.02 DnaQ family exonuclease/DinG family helicase 2693 
SAOUHSC_02155 0.02 hypothetical protein 380 
lyrA 0.02 hypothetical protein 1259 
mreD 0.03 hypothetical protein 530 
relQ 0.03 GTP pyrophosphokinase 635 
isaA 0.04 immunodominant antigen A 701 
ackA 0.04 acetate kinase 1202 
SAOUHSC_02646 0.04 hypothetical protein 455 
SAOUHSC_02279 0.04 hypothetical protein 662 
rplS 0.04 50S ribosomal protein L19 350 
SAOUHSC_01207 0.04 signal recognition particle protein 1367 
SAOUHSC_01732 0.05 hypothetical protein 350 
mreC 0.05 rod shape-determining protein MreC 842 
SAOUHSC_01025 0.05 hypothetical protein 1295 
oatA 0.05 hypothetical protein 1811 
SAOUHSC_00718 0.06 hypothetical protein 584 
SAOUHSC_02350 0.06 F0F1 ATP synthase subunit A 728 
rsbV 0.06 STAS domain-containing protein 326 
mazF 0.06 hypothetical protein 362 
SAOUHSC_01655 0.07 hypothetical protein 410 
SAOUHSC_01476 0.08 hypothetical protein 317 
SAOUHSC_02441 0.08 alkaline shock protein 23 509 
SAOUHSC_02627 0.08 hypothetical protein 902 
SpdD 0.09 hypothetical protein 743 
SAOUHSC_01863 0.09 hypothetical protein 311 
graS 0.09 hypothetical protein 1040 
SAOUHSC_02131 0.09 hypothetical protein 602 
SAOUHSC_00488 0.09 hypothetical protein 932 
SAOUHSC_01702 0.10 MTA/SAH nucleosidase 686 
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*Bolded genes were identified as top hits in both Dval and Mann-Whitney U tests  
 
3.4.3 Targeted Knockouts of Top Candidate Genes Confirm Sensitivity to WTA 
Depletion 
Transposons often inactivate the ORF into which they insert, but may allow 
transcription of a truncated mRNA and can also have indirect effects such as polar disruption 
of nearby genes. Because the top genes identified in the screen were well-saturated with 
transposon insertions in the control cultures (no tunicamycin), but had few or no insertions 
across multiple sites in the treated samples, it seemed likely that they were indeed 
synthetically lethal with WTA depletion (Supplementary File 1). To confirm that growth 
depletion was the result of gene inactivation, we selected a subset of the top ten genes 
spanning a range of growth depletion ratios and p values and prepared targeted knockouts in 
order to confirm susceptibility to tunicamycin. Knockouts tested included ΔgraR, ΔvraFG, 
ΔSAOUHSC_00965 (hereafter known as Δ965), and ΔlyrA. Because simultaneous deletion of 
LTAs and WTAs was predicted to be lethal, we also examined a strain that lacks LTAs 
(ΔltaS4S5) to examine its tunicamycin susceptibility(55; 168; 198)*. All strains were tested in 
a dilution series on agar plates with and without tunicamycin. Tunicamycin had no effect on 
the growth of wildtype S. aureus colonies, but prevented growth of the ΔltaS4S5 strain, 
consistent with a synthetic lethal interaction between the LTA and WTA pathways. The other 
mutant strains also exhibited tunicamycin sensitivity (Figure 3.4). Complementation with 
plasmid-borne copies of deleted genes restored growth in the presence of tunicamycin. These 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* Because library preparation involved a high temperature step and strains lacking LTAs are 
thermosensitive, we were unable to assess the ltaS locus from the growth depletion analysis 
as it was not well-represented in the control samples. 
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experiments showed that the genome-wide growth depletion analysis accurately identified 
genes that become essential when WTA synthesis is inhibited. Because ΔltaS4S5 contains a 
suppressor mutation that attenuates the function of the c-di-AMP phosphodiesterase gdpP, 
we also confirmed that the observed sensitivity of this strain to WTA depletion was 
specifically linked to deletion of the LTA pathway. We tested strains ANG2570 and 
JSM030, which have marked deletions of gdpP and found these strains grew equivalently to 
wildtype controls (Figure 3.5). Note that we were unable to obtain colonies from Newman 
ΔdltA transduced with a kanR-marked deletion of gdpP. 
 
Figure 3.4: Dilution series of selected wildtype and mutant strains grown in the 
absence and presence of 0.4 µg/mL tunicamycin. 
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Figure 3.5: Representative growth curves of selected strains grown in the presence and 
absence of 0.4 µg/mL tunicamycin at 37C, overnight, in a 96 well plate. Anhydrotetracycline 
(AT, 100ng/mL) was used to induce expression of gdpP for strain ANG2570. 
3.4.4 D-alanylation Becomes Essential When WTA Synthesis is Inhibited 
Four of the top ten genes identified in the transposon screen, graR, graS, vraF, and 
vraG, encode a regulatory protein complex comprising a two component signaling system 
and a two component ABC transporter (78; 79; 250). The GraRSVraFG complex regulates 
expression of lyrA, also in the top ten list, but it is best known for regulating the dltABCD 
operon (Figure 3.6A), which encodes the machinery that installs D-alanines on both LTAs 
and WTAs. Because Dlt null mutants are temperature-sensitive, there were almost no 
insertions in the dlt operon in the untreated library even though this modification is not 
essential in a wildtype background(11; 42). Therefore, the genome-wide growth depletion 
analysis did not provide information about possible synthetic interactions between the 
dltABCD genes and WTAs. To assess whether the D-alanylation pathway itself becomes 
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essential when WTAs are depleted, we constructed two Dlt null strains, ΔdltA and ΔdltD, and 
tested their sensitivity to WTA-inhibitory concentrations of tunicamycin (Figure 3.6B,C). 
Neither of the knockout strains grew on plates or in liquid media containing tunicamycin, but 
complementation with a plasmid expressing dltABCD restored growth. Hence, the D-
alanylation machinery is required when WTA expression is inhibited, implying that D-
alanylated LTAs are essential if WTAs are not produced. 
 
Figure 3.6: Identification and validation of Dlt- mutants as synthetically lethal with WTA 
depletion. (A) Four of the 10 most depleted genes encode the GraRSVraFG complex, which 
regulates expression of lyrA (purple) and the dlt genes (black). (B) Dilution series of wildtype 
and dlt knockout strains grown in the absence and presence of 0.4 µg/mL tunicamycin shows 
that the dlt deletion is synthetically lethal with WTA depletion. Complementation with the 
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dltABCD operon restored viability in the presence of tunicamcyin. (C) Growth of MW2 
wildtype and ΔdltA with and without tunicamycin treatment in 96 well format at 30°C. 
 
3.4.5 Linkage Analysis Provided Gene-Gene Validation of Compound-Gene Synthetic 
Lethal Interactions 
The primary target of tunicamycin in S. aureus is TarO, the first enzyme in the WTA 
biosynthetic pathway, but there is also a secondary target, MraY (234). Although our screen 
and follow up validation used tunicamycin concentrations that are two orders of magnitude 
below those that inhibit MraY, we wanted to confirm key results using a fully genetic 
approach that did not rely on a small molecule (44). This seemed necessary because some of 
the knockouts, including ΔdltA, ΔgraR, and ΔvraFG, are known to have increased 
susceptibility to cationic antimicrobial peptides (CAMPs) and certain other antibiotics with 
cell envelope targets (155; 179; 180). Increased susceptibility is proposed to occur because 
the cell surface lacks the D-alanine modifications that normally repel positively charged 
toxins at the envelope interface (192). While tunicamycin is not charged at physiological pH, 
we wanted to rule out increased access to MraY as an explanation for the lethal phenotypes 
we observed. We made strains with regulated, ectopic expression of TarO, but observed 
leaky expression in the absence of inducer. Therefore, we used linkage analysis to test 
synthetic lethality of double mutant combinations. We constructed a ΔtarO::tetR strain with a 
kanamycin-resistance gene installed in an intergenic region 4.3 kbp downstream. This strain 
contained a copy of tarO integrated elsewhere in the chromosome to enable the preparation 
of phage lysates. We then measured linkage of the two antibiotic resistance markers after 
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phage transduction into either the wildtype or mutant backgrounds (Figure 3.7)†. 
Transductants were selected on kanamycin plates and then scored for growth in media 
containing kanamycin, tetracycline, or Congo Red, an azo dye to which WTA-less S. aureus 
strains are highly sensitive (208). For the wildtype strain, approximately half the kanR 
transductants were both tetracycline resistant and Congo Red sensitive, indicating that the 
tarO deletion moves in tandem with the kanR marker 50% of the time. For the mutant 
strains, the compound sensitivity profiles showed that none of the kanR transductants 
contained the tarO deletion (Figure 3.7). This linkage disequilibrium confirmed synthetic 
lethality between ΔtarO and the other gene deletions, validating the screening results 
obtained using tunicamycin to inhibit WTA synthesis.  
 
Figure 3.7: Linkage analysis confirms compound-gene synthetic lethality. The ΔtarO::tetM 
locus could be transduced with the kanR gene (aphA3) into a wildtype background ~50% of 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  †	  We were unable to assess linkage in ΔdltD and ΔltaS4S5, as the former deletion was marked 
with kanamycin resistance, and ltaS and tarO are within close proximity of each other on the 
chromosome. 	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the time; it could not be transduced with the kanR gene into any of the tested mutant strains . 
WTA null recipients were identified by assaying for tetracycline resistance (TetR) and Congo 
Red susceptibility (Congo RedS). Because the ΔgraR strain was tet-marked, it could only be 
tested for Congo Red susceptibility. 
 
3.4.6 WTAs and LTAs Have Different Genetic Interactions  
WTAs and LTAs are proposed to play redundant cellular roles related to their anionic 
backbones. Having identified and validated a number of gene knockouts that are 
synthetically lethal with WTA removal, we next tested several of these in combination with 
LTA removal to determine if LTAs and WTAs have similar genetic interactions. We were 
able to transduce marked deletions of ΔdltD, Δ965, ΔlyrA, and ΔgraR into the ΔltaS4S5 strain 
and each of the double mutants was viable. Because WTAs and LTAs have distinct sets of 
genetic interactions, they function as part of different cellular networks/pathways. 
The network in Figure 3.8 summarizes the interactions between WTAs, LTAs, and 
several other genes. The WTA synthetic lethal interaction network includes, in addition to 
the LTA pathway, five signaling system components that regulate genes involved in 
modifying the cell envelope (VraFG, GraRS, YvqF/VraT) and two sets of genes that modify 
cell envelope components (dltABCD and oatA) (20; 37; 78; 79; 250). Three other genes in the 
WTA interaction network (lyrA, 965, and SAOUHSC_2256) encode structurally related 
membrane proteins that resemble type II CAAX prenyl endopeptidases, a family of proteins 
well-known in eukaryotes because key members are involved in the proteolytic processing of 
prenylated Ras and other lipoproteins (174). There are five genes encoding CAAX protease-
like (CPL) homologs in S. aureus, including the three identified in the growth depletion 
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analysis, but only ΔlyrA mutants have been characterized(99). These mutants have altered 
crosswall structures and are deficient in a subset of surface proteins (88), but as yet there is 
no evidence that LyrA has a proteolytic function. While a molecular understanding of CPL 
homologs in prokaryotes is still lacking, the results reported here emphasize the importance 
of this family of proteins for S. aureus cell envelope physiology. The screen also identified 
mreD, which encodes a broadly conserved membrane protein implicated in regulating 
peptidoglycan synthesis(134), providing the first genetic connection between two pathways, 
PG and WTA biosynthesis, that are proposed to be functionally coupled (11; 44; 184). 
 
Fig. 3.8: An interaction network showing cell envelope-related genes connected to the WTA 
pathway. Genes (nodes) group into several distinct pathways or clusters encoding similar 
proteins (colored boxes). Black lines connect viable double deletion mutants. Thin red lines 
depict selected synthetic lethal interactions identified only from the genome-wide growth 
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depletion analysis (growth depletion>85%; p<0.04); thick red lines depict synthetic lethal 
interactions that were confirmed in one or more follow up experiments. 
 
3.5 Discussion 
Dissecting the functions of teichoic acids presents numerous challenges. These 
polymers play many different roles and deletion phenotypes are pleiotropic. Moreover, 
mutants deficient in either polymer have similar cell division defects, showing that some 
functions are redundant. Because lipo- and wall teichoic acids have similar, highly charged 
backbone structures and identical tailoring modifications, it is also difficult to identify 
distinct sets of physicochemical interactions for the two polymers using biochemical 
approaches. We thought it might be possible to gain more insight into both redundant and 
unique roles of TAs by mapping their synthetic lethal interactions. Using a TarO inhibitor, 
we carried out an unbiased screen of a large transposon mutant library for cellular factors that 
become essential when WTAs are depleted. Based on a growth depletion analysis, we 
identified approximately two-dozen genes that became essential in the absence of WTAs. We 
followed up on a subset of the top ten candidates, and all of them confirmed. These results 
are a testament to both the selectivity of the chemical probe for TarO and the high saturation 
of the transposon mutant library, which provided statistical power in the analysis. Because 
the screen gave such robust results, we were able to use the data to construct a synthetic 
lethal interaction network for WTAs, which will be useful for elucidating cell wall 
physiology. It is worth noting that while pharmacological interrogation of transposon mutant 
libraries has been performed previously, all earlier studies focused on screening for factors 
that confer resistance to compounds that have essential targets, i.e., antibiotics. Our work 
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shows that small molecules that inhibit non-essential targets have tremendous value for 
elucidating pathway interactions. 
The LTA synthetic lethal network has not yet been mapped, but we tested several 
mutants that were not viable in the absence of WTAs for synthetic lethality with LTA 
deletion. All double mutant strains were fully viable, showing that WTAs and LTAs have 
distinct genetic interactions, although they comprise a synthetic lethal pair. In B. subtilis, 
LTAs are proposed to coordinate septal cell envelope synthesis while WTAs play a role in 
elongation(198). S. aureus does not have two distinct modes of cell wall synthesis, but the 
network analysis described here suggests that LTAs and WTAs act in different pathways to 
accomplish distinct as well as redundant functions.  
The work reported here highlights an important use for small molecule probes in 
mapping bacterial networks. In addition to revealing new biology, these interaction networks 
may provide target combinations for synthetically lethal antimicrobial compounds. From this 
study, we suggest that compound combinations that target both the WTA pathway and either 
D-alanylation or LTA synthesis are attractive because these factors are absent from humans 
and have previously been implicated in virulence/in vivo survival (45; 53; 59; 153; 190; 212; 
233). Synthetically lethal compound combinations that target these different cell envelope 
components may have potential as therapeutic agents against methicillin-resistant S. aureus 
(MRSA), which continues to be a serious threat to public health. 
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Chapter 4: Investigation of Synthetic Lethal Interactions between the WTA, LTA, and 
D-alanylation Pathways 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Work from this chapter is included in the article “Compound-gene interaction mapping 
reveals distinct roles for Staphylococcus aureus teichoic acids” by Santa Maria Jr., J.P., et al. 
(2014) Submitted. 
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4.1 Abstract  
 S. aureus mutants that lack WTAs and LTAs possess similar defects in cell division, 
yet have different viability and genetic interactions, suggesting that these polymers have non-
overlapping roles. Furthermore, our observation that the D-alanylation pathway becomes 
essential only in the absence of WTAs suggests that D-alanine esters of LTAs may mediate 
LTA-specific functions. Examination of terminal phenotypes following WTA depletion 
revealed that strains lacking LTA D-alanine esters died from envelope rupture during 
ongoing cell division, an effect that was not suppressed by single deletion of key autolysins. 
In contrast, strains lacking LTAs were unable to form Z rings and stopped dividing. Hence, 
the presence of either LTAs or WTAs on the cell surface is required for initiation of S. 
aureus cell division, but these polymers act as part of distinct cellular networks. 
4.2 Introduction 
 As discussed in Chapters 1 and 3, teichoic acids play fundamental roles in cell 
morphogenesis, PG biosynthesis, autolysis, adhesion and colonization, and susceptibility to 
host defenses and antibiotics. Because LTAs and WTAs possess similar structures (including 
D-alanyl ester modifications), lie in close physical proximity to one another in the cell 
envelope, and induce similar phenotypes upon deletion, it was assumed that teichoic acids 
have mostly redundant roles in these processes. Nevertheless, our analyses demonstrated that 
WTAs and LTAs have distinct genetic interactions with several pathways tested, suggesting 
they may also have unique or specialized functions. 
 Our observation that the D-alanylation pathway becomes essential only in the absence 
of WTAs argues that D-alanine esters of LTAs may mediate LTA-specific functions. The 
prior observation that GlcNAc modifications of WTAs alter MRSA beta lactam susceptibility 
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in a stereospecific manner provides early evidence for TA modifications in modulating 
specific interactions with cellular envelope factors (42). Saar-Dover and colleagues have 
argued that D-alanylation influences LTA conformations, changing the density and rigidity 
of the cell wall (192). Others have suggested that positively charged D-alanine esters on TAs 
negatively regulate hydrolytic enzymes, and removal of WTAs is also known to result in 
dysregulated autolysin activity (44; 166; 200). In order to gain insight into the nature of the 
synthetic lethality between WTAs and LTAs, as well as the specific function of D-alanine 
residues on LTAs when WTAs are depleted, we analyzed their phenotypes and raised 
suppressors. From our observations, we conclude that either LTAs or WTAs must be present 
in order for cell division to initiate.  
 
4.3 Methods 
 
 
4.3.1: Reagents and General Methods 
S. aureus was grown in tryptic soy broth (TSB) medium at 37°C. Fluorescein-
conjugated, amidated D-lysine was synthesized by Matthew Lebar of the Kahne lab (Figure 
4.1). Bacterial viability was assessed via a Live-Dead	  BacTiter-Glo™ (Promega). 
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Figure 4.1: Structure of fluorescent D-amino acid probe, amidated D-lysine conjugated to 
fluorescein. 
 
4.3.2 Electron Microscopy 
Overnight cultures were diluted into fresh TSB and grown to early exponential phase, 
before addition of tunicamycin. Cells were harvested by centrifugation after 2.5 or 5hrs and 
fixed using a mixture of 1.25% formaldehyde, 2.5 % glutaraldehyde and 0.03% picric acid in 
0.1M sodium cacodylate buffer, pH 7.4. Fixed cells were washed 3x in sodium cacodylate 
buffer, then incubated for 1hr in 1% OsO4/1.5% K4Fe(CN)6 in H2O, washed 3x in H2O, and 
dehydrated in ethanol. Cells were then incubated in propyleneoxide for 1 hour, then 
infiltrated with 1:1 Epon:propylene oxide for 2-3hrs, embedded in Epon, sectioned via 
microtome, and stained using uranyl acetate. 
 
4.3.3: Phase Contrast and Fluorescence Microscopy 
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Cells from exponential phase culture were pelleted and resuspended in 1X PBS. For 
fluorescent D-amino acid labeling, cells were resuspended in 1X PBS + 100µM D-amino 
acid conjugate and incubated for 1 minute, then diluted with 200µL of 1X PBS, pelleted, and 
resuspended in fresh 1X PBS. Cells were then mounted on slides covered with a 1% agarose 
in 1X PBS pad. Images were acquired with either a Hamamatsu digital camera (ORCA-ER) 
connected to a Nikon Eclipse TE2000-U microscope with an X-cite 120 illumination system 
or an Olympus BX61 microscope with a phase contrast objective UplanF1 100x and captured 
with a monochrome CoolSnapHQ digital camera (Photometrics). Image manipulation was 
limited to changing brightness and contrast via ImageJ or FIJI (197). 
 
4.3.4: Raising and Testing Suppressors of WTA and Dlt Synthetic Lethality 
Dilutions of stationary phase starter cultures were plated on TSB agar plates with (or 
without, for titering) 0.4µg/mL tunicamycin and grown for 24 hours at 37°C. 
Table 4.1 Strains used in this study 
Strains Relevant Genotype Reference or Source 
RN4220 
Δatl::kanR 
RN4220 Δatl::kanR Ting Pang, Bernhardt 
Lab 
HG003 
Δsle1::kanR 
HG003 Δsle1::kanR Ting Pang, Bernhardt 
Lab 
Newman ST8; CC8 isolated in 1952 human clinical 
MSSA 
(69) 
SEJ1 RN4220Δspa (100) 
4S5 SEJ1ΔltaS suppressor strain (55) 
JSM061 Newman ΔdltA This Thesis 
JSM157 SEJ1 [pLOWFtsZGFP] by transduction EmR This Thesis 
JSM158 4S5 [pLOWFtsZGFP] by transduction EmR This Thesis 
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JSM139 JSM061 [Δatl::kanR] by transduction, KmR This Thesis 
JSM138 JSM061 [Δsle1::kanR] by transduction, KmR This Thesis 
JSM162 MW2 [Δsle1::kanR] by transduction, KmR This Thesis 
JSM163 MW2 [Δatl::kanR] by transduction, KmR This Thesis 
 
Table 4.2 Plasmids and oligonucleotides used in this study 
pLOWFtsZGFP pLOW for expression of FtsZ-GFP CarbREmR (141) 
 
 
4.4 Results and Discussion 
 
4.4.1: LTA and Dlt Null Strains Depleted of WTAs Have Distinct Terminal Phenotypes 
We were surprised that D-alanylation becomes essential when WTAs, but not LTAs, 
are deleted because D-alanylation is a shared tailoring modification of LTAs and WTAs. As 
LTAs are themselves essential in the absence of WTAs, we wondered whether mutants 
lacking the entire LTA backbone would have a terminal phenotype upon WTA depletion 
similar to mutants lacking only the D-alanine modification. To address this question, we used 
electron microscopy to examine strains deficient in LTAs or D-alanylation after treatment 
with tunicamycin to deplete cells of WTAs. Compared to untreated wildtype (Figure 4.2A, 
Supplemental Folder 4), tunicamycin-treated cells have thickened crosswalls and impaired 
daughter cell separation. Moreover, successive division planes are frequently placed at non-
orthogonal angles and duplicated septa are common (note parallel crosswalls enclosing a 
narrow band of cytoplasmic material in Figure 4.2B) (44; 200). Cells lacking LTAs due to 
ltaS deletion showed similar defects in cell separation and septal placement (Figure 4.2C). 
These phenotypes, described previously, show that WTAs and LTAs help regulate S. aureus 
cell division (44; 52; 168; 200). The dlt null cells resembled untreated wildtype except for 
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irregularities in peptidoglycan thickness and membrane contour both at crosswalls and along 
the cell periphery. In addition, lysed cells (“ghosts”) were commonly observed (Figure 4.2D). 
These phenotypes imply that D-alanylation contributes to cell envelope integrity, either 
directly or through regulation of cell wall biosynthetic or hydrolytic enzymes. The 
ΔdltDΔltaS4S5 mutant appeared identical to the ΔltaS4S5 mutant, suggesting that deleting 
LTAs is epistatic to removing D-alanylation (Figure 4.3A, Supplemental Folder 5); however, 
dlt null strains in which WTAs were depleted showed defects characteristic of deficiencies in 
both pathways, but exaggerated. For example, crosswalls were mispositioned and daughter 
cells failed to separate as in WTA-deficient cells, but there were also marked aberrations in 
cell envelope ultrastructure characteristic of D-alanylation deficient cells (Figure 4.3B). 
Within five hours of treatment, nearly complete cell lysis was evident in treated samples, 
suggesting that the combined defects so weakened the cell envelope that rupture resulted 
(Figure 4.3C). Remarkably, the ΔltaS4S5 and ΔdltDΔltaS4S5 mutants depleted of WTAs did 
not resemble cells lacking only one type of TA. Whereas we frequently observed duplicated 
and misplaced crosswalls in images of cells lacking either WTAs or LTAs, we saw almost no 
crosswalls in fields of cells that had both polymers removed (Figure 4.3D). We confirmed 
that the lack of septa was not due to cell death - these cells were still viable as assessed by 
ATP production (via reaction with a luciferase kit), and plating in the absence of tunicamycin 
yielded colony growth. This suggested that at least one type of teichoic acid must be present 
in order for division to initiate and progress. 
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Figure 4.1: Effect of removing TAs and D-alanylation on cell morphology. Electron 
micrographs of S. aureus strains, grown in the presence and absence of 0.4µg/mL 
tunicamycin. To the left of each electron micrograph is a schematic showing the type of TAs 
present and their D-alanylation status. (A) WT cells, with division septa (black arrows); (B) 
WT cells treated with tunicamycin to remove WTAs. The dark line along the crosswall 
disappears and septal positioning is dysregulated (black arrows). Cells also fail to separate 
efficiently; (C) ΔltaS4S5 cells exhibit defects similar to strains lacking WTAs, with multiple 
septa, larger cell size, and deficiency in separation; (D) Both ΔdltA (shown) and ΔdltD 
(Supplemental Folder 4) mutants retain the dark midline at the crosswall (black arrow), but 
show several defects, including concavities in the cell membrane and irregular thickening of 
peptidoglycan (black asterisks) and ghost cells (black star). EM scale bars represent 500 nm. 
Additional fields of view are provided in Supplemental Folder 4. 
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Figure 4.3: Effect of removing TAs and D-alanylation on cell morphology. Electron 
micrographs of S. aureus strains, grown in the presence and absence of 0.4 µg/mL 
tunicamycin. To the left of each electron micrograph is a schematic showing the type of TAs 
and their D-alanylation status. (A) The ΔdltDΔltaS4S5 mutant exhibits defects similar to 
ΔltaS4S5, including non-orthogonal septation,larger cells, and deficiency in cell separation; 
Cells lacking D-alanylation and treated with tunicamycin for 2.5hrs (B) and 5hrs (C) exhibit 
exacerbated morphological defects, including impaired cell separation, increased incidence 
of membrane concavities and irregular peptidoglycan thickening, and improper placement 
and organization of septa; (D) ΔltaS4S5 cells treated with tunicamycin show near complete 
abolition of cell septation. Scale bars represent 500 nm. Additional fields of view are 
provided in Supplemental Folder 5. 
4.4.2: LTA Null Strains Depleted of WTAs Cannot Form Z Rings 
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FtsZ is the first intracellular protein to move to the division site during cell division, 
and is essential for recruiting other components of the division machinery (1). We wondered 
whether mutants lacking both LTAs and WTAs were blocked at the stage of FtsZ assembly 
or later in the division cascade. We transduced cells with FtsZ-GFP, grew them in the 
absence or presence of tunicamycin to deplete WTAs, and used fluorescence microscopy to 
assess Z ring formation. We observed rings of fluorescent FtsZ in wildtype cells, cells 
lacking only one TA polymer, and in cells lacking D-alanylation, but saw no Z rings in 
ΔltaS4S5 cells depleted of WTAs (Figure 4.4). Thus, simultaneous removal of both types of 
TAs results in an inability to assemble Z rings and cells can no longer divide.  
 
Figure 4.4: Effect of removing TAs on peptidoglycan biosynthesis and FtsZ localization. 
Light microscope images of S. aureus strains, grown in the presence and absence of 0.4 
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µg/mL tunicamycin. (A) Localization of FtsZ-GFP in untreated (left) and tunicamycin-
treated (right) ΔltaS4S5 cells. Scale bars represent 1 µm; (B) ΔltaS4S5 treated with tunicamycin 
lacked septal fluorescence incomparison to the other conditions (p<10   by two-tailed t-test). 
(C) Newman ΔdltA with and without tunicamycin treatment showed localized FtsZ patterns. 
Additional fields of view are provided in Supplemental Folder 5. 
4.4.3: Cells Lacking D-alanylated LTAs Have Altered PG Biosynthesis 
Previous work from our lab has revealed a synthetic lethal relationship between WTA 
and PG biosynthesis, implying a functional connection between the two pathways (44). 
Others have shown that removing WTAs alters the localization of PBP4, and that WTA 
polymers physically interact with PBP2A and FmtA (11; 184). Concomitantly, strains 
lacking WTAs have decreased PG cross-linking by muropeptide analysis (200). In order to 
determine whether removal of D-alanylation and/or LTAs also affected PG biosynthesis, we 
treated cells with a fluorescein-conjugated D-lysine analog. This fluorescent D-amino acid is 
believed to be incorporated at sites of nascent PG biosynthesis in S. aureus via the back 
reaction of DD-carboxypeptidases (132).Treatment of wildtype and ΔdltA cells with the 
probe for 1 minute resulted in localized fluorescence characteristic of nascent PG 
biosynthesis as described by others using BODIPY-vancomycin conjugates (Figure 4.5) 
(219). Upon tunicamycin treatment, wildtype cells exhibited more diffuse fluorescence than 
untreated cells, while ΔdltA cells retained punctate fluorescence with a greater number of 
foci per cell. The mutant’s altered localization pattern did not correlate with dead cells as 
assessed by propidium iodide staining. This suggested the observation was not an artifact of 
cell death, and that dysregulated PG biosynthesis precedes lysis.  
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These data provide further evidence for WTAs playing a role in modulating PG 
biosynthesis, and reveal a new role for LTAs lacking D-alanylation in directing nascent PG 
biosynthesis. In their transmission electron micrographs, Saar-Dover and colleagues reported 
that mutants lacking TA D-alanylation had increased cell wall density (192). While this was 
attributed primarily to the role of D-alanines in influencing LTA conformation at the 
membrane interface, our data suggest that D-alanines of LTAs regulate PG crosslinking. In 
treating ΔltaS4S5 mutants with the fluorescent probe, we observed low incorporation 
independent of tunicamycin treatment; however, this mutant is known to contain a suppressor 
mutation in the c-di-AMP phosphodiesterase GdpP attenuating its function, and ΔgdpP 
mutants exhibit a higher degree of muropeptide crosslinking, which may interfere with 
incorporation of the probe (55). 
 
Figure 4.5: Treatment of Newman WT and ΔdltA with fluorescein-conjugated, amidated D-
lysine to label sites of nascent PG biosynthesis. Further treatment with tunicamycin altered 
the localization pattern for each strain. Scale bar represents 2µm. 	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4.4.4: Deletion of Key Autolysins Does Not Suppress Synthetic Lethality Between the D-
alanylation and WTA Pathways 
 Murein hydrolases serve a variety of roles in bacterial physiology by catalyzing 
turnover and modification of the cell wall. In S. aureus, PG hydrolases are required for the 
proper separation of daughter cells after septal PG deposition - mutants defective in Atl 
(bifunctional N-acetylmuramoyl-L-Ala amidase and endo-beta-N-acetylglucosaminidase), 
Sle1 (also known as Aaa, N-acetylmuramoyl-L-Ala amidase), and LytN (bifunctional N-
acetylmuramyl-L-Ala-amidase and D-Ala-Gly endopeptidase) form characteristic aggregates 
of cells (87; 118; 207). Both WTAs and D-alanylation are known to regulate autolysin 
function. ΔtarO mutants exhibit elevated autolysis and lose septal localization of Atl by 
immunofluorescence microscopy (200). In contrast, tunicamycin enabled the septal 
localization of exogenously applied, fluorescent Sle1 and LytN (though this phenotype was 
not observed in a ΔtarO mutant(89). ΔdltA mutants also exhibit increased autolysis and it has 
been proposed that D-alanine esters modulate hydrolase activity by masking TA binding sites 
from positively-charged autolysin repeat domains (166; 256). 
 Previous genetic experiments have demonstrated that deletion of both Atl and Sle1 is 
synthetically lethal. Because WTAs and D-alanylation are known regulators of autolysins 
and are also synthetically lethal with each other, we wondered whether we could combine 
disruptions of these factors to map pathway-specific associations. We were able to construct 
deletion strains ΔatlΔdltA and Δsle1ΔdltA, which argued that TA D-alanylation is either in 
the same functional pathway as these autolysins, or acts independently of them. Furthermore, 
we found that Δatl and Δsle1 were not killed by tunicamycin treatment. Electron microscopy 
revealed that strains under these conditions were mostly arrested in cell division (Figure 4.6, 
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Supplemental Folder 4). ΔatlΔdltA and Δsle1ΔdltA mutants appeared similar to both parent 
single mutants in possessing defects in cell separation and displaying occasional “ghost” cells 
due to lysis (Figure 4.7, Supplemental Folder 4). Upon tunicamycin treatment, these mutants 
appeared very similar to ΔdltA mutants treated with tunicamycin, revealing that single 
deletion of two major autolysins, Atl and Sle1, does not abrogate the synthetic lethality 
between the WTA and Dlt pathways. Additional hydrolases not associated with lysogenic 
phage can be found in the S. aureus genome (e.g. amiC, lytX, lytY, and lytZ) - though 
biochemical characterization of the encoded proteins has not yet been reported, it is possible 
that these other autolysins may become dysregulated upon removal of D-alanylation and 
WTAs, or that PG hydrolysis may not play a role in this synthetic lethal interaction.  
 
Figure 4.6: Electron micrographs of Δatl and Δsle1 mutants with and without 0.4 µg/mL 
tunicamycin treatment for 1 hr. Scale bars represent 500µm. 
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Figure 4.7: Electron micrographs of ΔatlΔdltA and Δsle1ΔdltA mutants with and without 
0.4µg/mL tunicamycin treatment for 2.5hrs to deplete WTAs. Scale bars represent 500 nm. 
4.4.5: Dlt and LTA Mutants Depleted of WTAs Have Different Suppressibility 
 In order to gain insight into the biological mechanism behind the observed synthetic 
lethality between the Dlt and LTA pathways and WTAs, we attempted to raise suppressor 
mutants. The frequency by which mutants arise provides insight into the nature of 
suppression, and assessing mutant phentoypes, in addition to sequencing, can provide 
information about how suppressors alter the function of their target. Attempts to raise 
suppressors from ΔltaS4S5 treated with tunicamycin proved unsuccessful, which suggested a 
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frequency of <10-9. This observation argued that either synthetic lethality is unable to be 
suppressed, or that a combination of mutations is necessary to restore growth in the presence 
of tunicamycin. In contrast, we raised colonies on plates from ΔdltA and ΔdltD treated with 
tunicamycin at frequencies in the range of 10-6 to 10-7. This suggested, though did not prove 
that loss-of-function mutations could alleviate the synthetic lethality between the Dlt and 
WTA pathways. Further studies to characterize suppressor mutants that remain WTA-null 
may identify cellular factor(s) that connect the WTA and Dlt pathways. 
 
4.5 Conclusion 
We found that D-alanylation became essential on LTAs when WTAs were removed, 
but was not essential on WTAs when LTAs were removed. The D-alanine deficient cells had 
defects in cell wall ultrastructure and displayed increased lysis, showing that the D-alanine 
modification on LTAs contributes to membrane integrity. The combined defects from 
removal of WTAs and D-alanylation evidently lead to catastrophic cell envelope damage 
during ongoing cell division. This lysis does not appear to be mediated by the autolysins Atl 
and Sle1, though we cannot rule out the activity of other autolysins not tested. Instead, it 
appeared by fluorescent D-amino acid incorporation that PG biosynthesis became 
dysregulated in Dlt- mutants treated with tunicamycin. 
An unexpected result to emerge from our studies was that simultaneous removal of 
LTAs and WTAs prevents FtsZ ring assembly and causes cell division to cease. FtsZ 
polymers serve as a scaffold for the recruitment and organization of division proteins at the 
septum. How extracellular TA polymers can influence the intracellular organization of 
division machinery remains unclear. Several proteins such as the nucleoid occlusion factor 
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(Noc), FtsA, and EzrA are known regulators of FtsZ polymerization, and both DNA damage 
and the stringent response can affect Z ring assembly (1), so it is possible that removing TAs 
activates these pathways. Alternatively, removing both kinds of teichoic acids may also 
affects membrane potential, which is known to affect FtsZ and FtsA association with the 
membrane (31, )	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Chapter 5: High-Throughput Pathway-Directed Chemical Screens to Identify Synthetic 
Lethal Inhibitors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The experiments described in this chapter have been performed in collaboration with Lincoln 
Pasquina of the Walker Lab.  
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5.1 Abstract 
 Innovative strategies are needed to combat the imminent threat of antibiotic resistant 
bacterial infections. Chapter 3 described a method for identifying new synthetic lethal target 
pairs. Here we demonstrate that one can seamlessly transition to screen for chemical 
inhibitors of identified targets using strains created to validate synthetic lethal interactions. 
We screened ~41,000 compounds looking for inhibitors of the WTA and Dlt pathways. In 
addition to rapidly eliminating ineffective and toxic compounds, we found and reconfirmed 
several primary hits, generating new chemical matter for target identification and lead 
optimization. Thus, parallel, pathway-directed screening is a new and useful approach for 
identifying chemical inhibitors within a pathway of interest that can be used in investigation 
of pathway biology and for synthetic lethal compound combinations.    
 
5.2 Introduction 
The current rise in the prevalence of antibiotic-resistant infections in combination 
with the “discovery void” or “innovation gap” representing a lack of newly developed 
candidate antibiotics portends a dangerously imminent return to the pre-antibiotic era. While 
new governmental incentives such as the Generating Antibiotic Incentives Now (GAIN) Act 
hope to promote growth and development in this area, the concurrent exit of many 
pharmaceutical giants from the antimicrobial sector relegates the responsibility of finding 
promising lead compounds to academic labs. In this vein, academia has generally been 
afforded greater flexibility in its research pursuits, leading to the investigation of numerous 
alternative strategies to traditional antibiotics in order to combat the problem of drug-
resistant bacteria (90). 
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Compound combinations have been touted as a promising new approach to targeting 
bacterial infections. Such cocktails may help lower the incidence of drug resistance and 
expand our current range of targets(230). Some combinations have already been employed 
clinically, such as Synercid and trimethoprim/sulfamethoxazole. Each of these combinations 
is composed of synergistic compounds targeting the same complex or pathway. In contrast, 
the combination of a beta-lactamase inhibitor and a beta-lactam, Augmentin, works by first 
disabling the bacteria’s resistance mechanism, thus allowing the beta-lactam to more fully 
inhibit its intended targets, transpeptidases that construct the cell wall. Recently, it was 
shown that simple metabolic products, such as fumarate and mannitol, can potentiate the 
effects of traditional antibiotics – while the mechanism is being actively investigated, 
researchers have proposed that these compounds serve to perturb the metabolic state of the 
cell, causing them to become more susceptible to oxidative damage and increase drug uptake 
(3).  
 Because of their combinatorial nature, probing compound cocktails for efficacy in 
antibacterial screens can be prohibitive. Previous screens have been limited to known 
antibiotics in combination with previously approved drugs or bioactives (71; 213). Another 
approach has been to keep one drug constant, and look for compounds that potentiate its 
effect. We, and others have specifically applied this approach to find compounds that restore 
beta-lactam susceptibility to MRSA strains (80; 111; 215; 233). One major disadvantage of 
this approach is that there may be several underlying genetic factors that may contribute to 
compound sensitivity, leading to high hit rates and difficulties in target identification. For 
example, several genes are known to contribute to β-lactam resistance in MRSA making it 
difficult to immediately discern compound interactions and mechanism of action (21; 44). 
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Pathway-directed screening is one way to combat the target identification problem. In 
this method, wildtype and pathway-deficient mutants are screened in parallel, with the aim of 
identifying hits as differentially killing the mutant strain that act within the pathway of 
interest. By assaying wild-type and ΔtarO strains, the Walker lab employed this technique to 
discover 1835F03, a late-stage inhibitor of the S. aureus WTA biosynthetic pathway (212), 
and later researchers from Merck replicated this approach to identify additional inhibitors for 
the same target (233). 
In Chapter 3, I described a method for identifying synthetic lethal gene pairs that 
when simultaneously disrupted lead to cell death. In the process of validating these 
interactions, we generated single knockout mutants for each of the gene pairs. These 
materials were then directly translated into parallel, pathway-specific screens to search for 
compounds that inhibit each half of the synthetic lethal interaction between the WTA and D-
alanylation pathways (Figure 5.1). Both of these pathways are known virulence targets, yet 
the combination of antivirulence inhibitors targeting each factor would be predicted to have a 
lethal effect for S. aureus (45; 53; 59; 153; 190; 212; 233). We found that parallel screening 
improved discriminatory power, enabling rapid classification of compounds into classes and 
removal of undesired classes, such as generally toxic and ineffective compounds. We 
obtained and validated a small number of hits that we are currently investigating, in order to 
identify their targets and mechanisms of action. 
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Figure 5.1: Parallel, pathway-directed screening approach for the discovery of small 
molecules targeting the synthetic lethal interaction between the WTA and Dlt pathways. Hits 
were classified into subcategories based on differential killing of the screened strains 
 
5.3 Methods 
 
5.3.1 Screening Protocol 
The night before screening, a starter culture of each strain was inoculated in tryptic 
soy broth (TSB) and grown until stationary phase. Thirty microliters of TSB was dispensed 
into all wells in lanes 1–23 of a 384-well plate (Corning® 3009) using a Matrix WellMate® 
plate filler and stacker. Controls were as follows: wells in lane 23 served as negative controls 
for full growth in the absence of any inhibitors; wells A–L in lane 24 served as positive 
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controls for the growth inhibitory activity of synthetic lethal inhibitors and contained final 
concentrations of 0.4 µg/mL tunicamycin for the ∆dltA strain and 10 µg/mL erythromycin for 
the WT and ∆tarO strains. DMSO stock solutions of library compounds (300 nL) were then 
pin-transferred into lanes 1–22 of duplicate plates. Following compound transfer, an 
additional 50 µL of TSB containing approximately 2 x 10^6 CFU/mL of S. aureus (1000-
fold dilution of overnight culture) were dispensed into all wells of all of the plates. Plates 
were stacked five-high, covered, and incubated at 30 °C for 16 hours. Each strain was tested 
in duplicate for every compound (6 plates total per compound). The optical density of each 
well at 600 nm was read on a PerkinElmer Envision plate reader. Raw absorbance 
measurements were averaged across replicates and compared pairwise between the strains. 
Hits were determined as possessing a Z score of > 4.7 (p<.000001, by Bonferroni correction), 
and further classified into categories based on strain-specific killing. Compounds were 
classified as toxic if they gave OD600 measurements within one standard deviation of the 
mode of the death peak for each strain. Compounds were classified as having no effect on 
growth if it yielded OD600 measurements within one standard deviation of the mode of 
maximal bacterial growth for each strain. 
 
5.3.2 Secondary Assay to Confirm Cherry Picks 
 Compounds and control diluent (DMSO) were diluted into wells of a 384-well plate 
to produce a series of concentrations at equivalent volumes using the Hewlett-Packard D300 
Digital Dispenser. After 16 hours of growth at 30 °C, OD600 was measured using a Molecular 
Devices SpectraMax Plus 384 well plate reader. 
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5.3.3 Construction of a DltA Linkage Construct 
 PCR amplification products from P1-P2, P3-P4, and P5-P6 were cloned into 
BamHI/EcoRI-digested pKFC using a Clontech InFusion HD kit. 
Table 5.1: Strains used in this study 
Strains Relevant Genotype Reference or 
Source 
Newman ST8; CC8 isolated in 1952 human clinical MSSA  
Newman 
ΔtarO 
Newman [ΔtarO::tetR] by transduction, TcR  
JSM061 Newman ΔdltA This Study 
Newman ΔdltC Newman ΔdltC::aphA3, KmR Leigh Matano 
MW2 
(USA300) 
Clinical isolate; community-acquired methicillin 
resistant (CA-MRSA) 
(12) 
MW2ΔdltA  (42) 
SA113 Agr, restriction-modfication-deficient derivate of 
NCTC8325 
(179) 
SA113ΔdltA  (179) 
SEJ1 RN4220Δspa (100) 
4S5 SEJ1ΔltaS suppressor strain (55) 
JSM096 TCM011 with aphA3::kanR installed upstream of the dlt 
operon 
This Study 
 
Table 5.2: Oligonucleotides and plasmids used in this study 
Plasmids   
pKFC Temperature-sensitive shuttle vector; oriTs 
CarbRCmR 
(120) 
pKFCdltAlinkkan P1-P4 PCR in pKFC for installation of aphA-3 
downstream of the dlt operon CarbRKmR CmR 
This Study 
P1. dltAlink upFor GACGGCCAGTGAATTCattagtgcctatgcctaaag  
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P2: dltAlink 
upRev 
ACCTCAAATGGTTCGCcattaatatgacgagtttataat  
P3: dltAlink 
downFor 
GTTTTAGTACCTAGGtgatgagtttatttgattttgac  
P4: dltAlink 
downRev 
CGACTCTAGAGGATCaaatcgttgggaagaatgaa  
P5: aphA3 For gcgaaccatttgaggtgat  
P6: aphA3 Rev cctaggtactaaaacaattcat  
 
 
5.4 Results & Discussion 
 
5.4.1 Parallel, Pathway-directed Screening Identified Compounds Selectively Killing 
WTA and Dlt- Mutants  
 We screened 41,087 compounds belonging to 3 chemical classes (commercial vendor 
library compounds, CVL, known bioactives, KB, and natural products, NP) (Table 5.3). As 
predicted, we observed innate differences in maximum OD600 and compound sensitivity 
between the strains (Figure 5.2), with ΔtarO having an average OD600 below both wildtype 
and ΔdltA strains. Therefore, we employed principal component analysis in pairwise 
comparison of growth measurements for each compound to identify compounds that 
selectively killed certain strains (Figure 5.3). We binned hits into the following categories: (i) 
selectively killed ΔtarO; (ii) selectively killed ΔdltA; (iii) killed both ΔtarO and ΔdltA, but 
not wildtype; (iv) protected ΔdltA or ΔtarO. We were able to immediately remove 34,323 
compounds from consideration as generally toxic or ineffective, supporting parallel screening 
as an approach to quickly identify compounds potentially affecting bacterial growth by a 
specific mechanism of interest.  
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Figure 5.2: Summary of frequencies of observed bacterial growth for each of the screened 
strains. 
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Figure 5.3: Observed distribution of compounds based on pairwise comparison of their 
effects on bacterial growth. Compounds in red have Z > 4.7. 
Table 5.3 Summary of Screen Library and Hit Information 
 CVL Known 
Bioactives 
Natural 
Product 
Total   
Total 
Compounds 
Screened: 
19418 7237 14432 41087   
Identified Hits 
(|Z|>4.7): 
11 27 36 74   
Validated 
Cherry Picks: 
2 15 5    
 WT ΔdltA ΔtarO    
Average Z-
factor: 
.845 .733 .683    
 WT/ΔdltA WT/ΔtarO ΔdltA 
ΔtarO 
   
Total Hits: 67 7 11    
        CVL 9 0 2    
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           KB 30 3 5    
           NP 28 4 4    
Validated 
Cherry Picks: 
19 0 3    
       
Hit Classes I II III  Generally 
Toxic 
Ineffective 
Total Hits: 4 67 3  1090 33233 
         CVL 0 9 0    
            KB 0 30 3    
            NP 4 28 0    
Validated 
Cherry Picks: 
2 21 3    
 
5.4.2 Cherry Picking & Validation 
We observed a low hit rate of 0.21%, with a disproportionate majority of hits 
identified in the known bioactives class. Overall, we found a larger number of compounds 
that selectively killed the ΔdltA strain, - however, this may be a function of library 
composition. Indeed, the majority of hit compounds in category II were known bioactives, 
and many have been previously described as compounds to which ΔdltA mutants are 
sensitized. Furthermore, strains lacking D-alanylation are known to have compromised 
membrane integrity, resulting in increased uptake of positively charged compounds (192). In 
order to confirm the observed effect of compound hits on bacterial growth, we cherry-picked 
a subset from each class and tested their effect on growth of a larger subset of strains in dose-
dependent format. Out of 41 unique compounds retested, we validated 22 as having dose-
dependent and strain-specific inhibition of bacterial growth. These compounds were tested on 
deletion mutants in other background strains to further corroborate killing dependent on the 
deleted pathway (Figure 5.4). 
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Figure 5.4:	  Effect of several hit compounds on the growth of wildtype, ΔtarO and ΔdltA 
strains. 
 
5.4.3 Hit Analysis 
 Hits were filtered to remove promiscuous screen positives, i.e. compounds that were 
identified as active in multiple, orthogonal high-throughput screens through query of the 
ICCB Screensaver and Pubchem databases. Four hits were natural products, which await 
	  	   107	  
isolation, structural characterization, and further assays for biological activity. The remaining 
hits were mostly known bioactives, which grouped into several classes based on shared 
structural similarities and/or similar targets and mechanisms of action. Four hits 
(diethylstilbestrol, hexestrol, toremifene, and tamoxifen) are known antagonists of the human 
estrogen receptor. They share a tetrasubstituted diphenyl ethylene core, and several have 
been previously reported as having Gram-positive specific antimicrobial activity, despite the 
absence of sequence (PSI-BLAST) or structural (FATCAT) homologs of the human target in 
S. aureus. While no mechanism of killing as been confirmed, these agents have exhibited 
synergy with other membrane actives, suggesting that it is the compromised membrane 
integrity of the D-alanylation mutant that sensitizes these mutants independent of interaction 
with the wall teichoic acid pathway (64; 67; 252). This appears to be similar for pentamidine, 
which has been characterized as a disruptor of the protein-protein interaction between p53 
and S100B, but has been described as a promiscuous synergizer acting within the cell 
membrane, potentiating the activity of numerous other antibiotics in yeast (51; 140; 147). In 
contrast, mitoxantrone and amsacrine are structurally distinct inhibitors of human 
topoisomerase II. The S. aureus homologs Gyr/GrlAB are validated antibiotic targets of the 
clinical quinolone and coumerin drug classes. Interestingly, the former selectively inhibits 
the growth of the ΔdltA mutant, while the latter inhibits ΔtarO. This suggests that the 
efficacy of these compounds may be explained by their physicochemical properties and not 
interactions between these pathways and essential DNA replication. This hypothesis is 
supported by our previous observation that tunicamycin does not significantly potentiate the 
antibacterial activity of ciprofloxacin. We also identified several aminoglycoside antibiotics 
(amikacin, apramycin, bekanamycin, gentamicine) as selective killers of ΔdltA, and the 
	  	   108	  
increased susceptibility of these mutants is attributed to a decrease in the positive charge of 
the cell surface, which normally serves to repel these positively charged drugs. Finally, 
flavonoids such as epigallocatechin gallate and epicatechin gallate have been studied 
extensively for their activity as beta-lactam sensitizers in staphylococci (23; 24; 206). These 
compounds have been found to disrupt the cell membrane, causing a reduction in d-
alanylation and mislocalization of PBP2, but they are not believed to have specific 
interactions with Dlt or WTA machinery. Nevertheless, there are multiple cellular factors 
beyond the Dlt enzymes that are synthetically lethal with the WTA pathway, and compounds 
that show ΔtarO-specific killing may be exploiting these alternative targets. Similarly, 
identification of genes synthetically lethal with deletion of the Dlt pathway may provide 
insight into the targets of compounds that killed the ΔdltA strain. 
 
5.5 Conclusion 
 We conducted a small molecule screen using three different strains in order to 
identify compounds that exploited the synthetic lethality between the WTA and TA D-
alanylation pathways. After compound identification and validation, we now have a 
collection of promising small molecules that await target identification, potential SAR, and 
efficacy studies in alternate biochemical and phenotypic assays. Parallel screening represents 
a promising approach for the discovery of inhibitors that exploit identified synthetic lethal 
interactions. 
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Summary, Remaining Questions, and Future Directions 
Wall teichoic acids play important roles in the biology of Gram-positives. We sought 
to further characterize the functions of WTAs in S. aureus by performing a synthetic lethality 
screen. We created a highly saturated transposon library, treated it with the TarO inhibitor 
tunicamycin, and identified and validated a subset of genes in multiple cell envelope 
pathways. Among these genes were those involved in TA D-alanylation and LTA 
biosynthesis. We chose to further investigate these synthetic lethal interactions and found 
that cells lacking WTAs and D-alanylation lyse, while cells lacking both LTAs and WTAs 
stop dividing. Finally, we conducted a pathway-directed, high-throughput screen to 
identifying compound combinations that exploit cell wall synthetic lethal interactions. 
While we have discovered novel interactions with the WTA pathway of S. aureus and 
outlined a new pipeline for identifying synthetic lethal compound combinations, questions 
old and new remain. These include: 
- Validation of additional genes identified as synthetic lethal when deleted in the 
absence of WTAs. While we validated all genes that we selected in the list of top 10 
candidates, there are additional genes both within and outside of our thresholds that 
await further investigation. Because gene deletions remain challenging in S. aureus, it 
may be possible to verify the status of these genes using selected transposon mutants 
from the Nebraska library. Furthermore, we were unable to assess all ORFs for 
synthetic lethality due to their low coverage or absence in the transposon library. 
Advances in transposon delivery and alterations of transposon structure (e.g. 
incorporation of outward facing promoters and transcriptional terminators) will not 
only afford better coverage to other libraries; it will also enable one to assay the effect 
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of modulating gene dosage genome-wide on interaction with the WTA pathway. This 
also facilitates the query of essential genes, by enabling downregulation instead of 
only blunt disruption. 
- Assessment of intragenic and intergenic regions for synthetic lethality. We primarily 
employed the Mann-Whitney U test to identify candidate ORFs synthetically lethal 
with depletion of WTAs, but this method ignores additional genomic features such as 
small RNAs and promoter and terminator elements. Newer methods such as Hidden 
Markov Modeling enable the interrogation of these regions, as well as the 
contribution of individual domains within a gene to mutant viability. 
- Absolute quantification of genetic interactions or fitness with depletion of WTAs.  In 
the first TnSeq experiment, van Opijnen & colleagues quantified genetic interactions 
by calculating the expansion of transposon mutants within the library. Though we 
used PCR reads as a surrogate for mutant abundance at a final time point, it is 
possible to directly calculate mutant growth rates by obtaining samples at several time 
points before and at stationary phase. This approach has an advantage of profiling 
mutant growth over time, and may serve as a better indicator of fitness in a test 
condition. 
- Generation of a cell wall interactome.  Our experiments, centered on the WTA 
pathway, were facilitated through the use of tunicamycin as a specific and nonlethal 
inhibitor of TarO. Similar inhibitors for other cell wall targets, or less preferably, 
constructing transposon libraries in deletion mutant backgrounds will generate 
additional networks to elucidate functional connections between cell envelope 
components. 
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- Characterization of mechanisms of synthetic lethal interactions. Using tunicamycin to 
inhibit WTA biosynthesis provided the ability to remove WTA polymers without 
disrupting potential protein-protein interactions of the WTA biosynthetic enzymes 
(though it is possible that tunicamycin binding induced an alternate conformation of 
TarO and had a resulting effect on its interactions). A major question that remains for 
each of the WTA interaction partners is whether lethality is the result of a disrupted, 
directed physicochemical interaction with WTA polymers, or whether it is caused 
indirectly, through an intermediate factor. For several factors, such as lyrA and 965, 
we are unsure of their physiological roles, and elucidating the mechanism of synthetic 
lethality will first require characterizing the phenotypes of knockout mutants. Once 
their functions are clarified, one can then interrogate the effect of blocking WTA 
surface expression on this function, and design experiments to test for alterations of 
protein localization, abundance, enzymatic activity, or conformational change. We 
have also attempted to identify mechanisms by isolating resistant mutants of ΔdltA 
strains treated with tunicamycin, and identification of the genetic determinants of this 
resistance may shed light on the nature of the interaction between the WTA and D-
alanylation pathways.  
- Elucidation of the role of D-alanylation in teichoic acid function. We observed 
conditional essentiality of TA D-alanylation only when WTAs, but not LTAs were 
depleted. While several questions remain regarding how D-alanylation occurs (i.e. 
substrates and function of DltB and DltD, location of the alanylation reaction within 
the envelope, and whether D-alanines are transferred enzymatically between LTAs 
and WTAs), our experiments suggest a key functional role for the D-alanines of 
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LTAs in the cell envelope. Recent findings provide support for TA modifications 
mediating specific physicochemical interactions and proteomic characterization of 
pulldowns using WTAs isolated from wildtype and D-alanylation deficient mutants 
may identify proteins whose binding to TAs is modulated by TA D-alanylation state 
(42). 
- Illumination of the mechanism of TA control of cell division. We provided evidence 
that removal of both WTAs and LTAs prevents the formation of FtsZ rings and 
abolishes cell division altogether. However, it remains unclear how extracellular TA 
polymers influence the assembly and activity of cytoplasmic divisome components, 
and whether TA regulation of division is mediated by specific physical interactions or 
by general perturbation of envelope structure. We hypothesize that mreD, also 
identified as synthetically lethal with WTA depletion, may be key in mediating 
interactions between WTA, PG, and division machinery.  
- Identification of the function of bacterial CAAX-like protease homologs. Though we 
identified several proteins of unknown function as synthetically lethal with WTA 
depletion, 3 of the top candidates (2 of which we validated) possessed CAAX-like 
domains. While this family of enzymes is implicated in the proteolytic processing of 
prenylated proteins in eukaryotes, the function of these proteins is largely unknown in 
bacteria. In B. subtilis, PrsW was implicated in proteolysis of an anti-sigma factor that 
represses gene expression, thereby leading to activation of cell wall stress response 
pathways (73). However, in S. aureus, these proteins were implicated in the sorting of 
surface proteins with YSIRK signal peptides (in S. aureus HG003, these include 
SAOUHSC genes spa, 300, 1079, lytN, 1843, 1873, sasB, 2798, and 3006) (88). The 
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use of fluorescent protein fusions and the construction of transposon libraries in 
deletion mutant backgrounds may help determine the function of these proteins and 
their role in sorting proteins in the cell envelope. 
- Validation of Putative Pathway-Specific Inhibitors. Though we have identified 
several compounds that specifically kill ΔdltA and/or ΔtarO, these compounds must 
be further validated in follow-up biochemical and phenotypic assays to confirm their 
action within the pathways of interest. As we have identified multiple cellular targets 
that are synthetically lethal with removal of WTAs, it is possible that compounds that 
kill ΔtarO may hit these factors over Dlt pathway enzymes. Alternatively, these 
compounds may lack specific targets, but gain increased access to the cytoplasm or 
membrane due to inherent defects in the ΔdltA and ΔtarO cell envelopes. We have 
generated multiple deletion and complemented mutants within different pathway 
enzymes to corroborate findings with the ΔdltA and ΔtarO strains. Furthermore, 
extensive characterization of ΔtarO strains has provided numerous orthogonal assays 
to test inhibition of WTA production (e.g. WTA PAGE, sensitization with Congo 
Red, synergism with β-lactams, antagonism of Congo Red). Finally, recent work by 
B. McKay Wood of the Walker lab has led to the reconstitution of DltA for in vitro 
inhibition assays. 
- Generate new antibiotics and new targets for cell envelope active antibiotics. We 
have shown that transposon mutagenesis is a valuable tool for discovering new 
synthetic lethal interactions when used in combination with a nonlethal small 
molecule inhibitor of a pathway of interest. We also demonstrated a screening 
technique to find new small molecule inhibitors of identified synthetic lethal targets. 
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It is our hope that these compounds can be exploited both therapeutically and as 
probes to investigate pathway biology. 
-   
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Appendix A: Electron Microscopy of Treatment with a Putative LtaS Inhibitor 
 
A.1: Introduction 
 Because mutants lacking LTAs are severely compromised in fitness, inhibitors of the 
LTA biosynthesis pathway are attractive candidates for development as traditional 
antibiotics. S. aureus mutants lacking LTAs cannot grow at high temperatures and must be 
osmotically stabilized unless several suppressor mutations are present. Richter and 
colleagues designed a small molecule screen that exploited the temperature sensitivity of 
LTA mutants and surveyed compounds that only killed S. aureus at high temperatures. They 
reported Compound 1771 (2-oxo-2-(5-phenyl-1,3,4-oxadiazol-2- ylamino)ethyl 2-
naphtho[2,1-b]furan-1-ylacetate) as an inhibitor of S. aureus LtaS (190). Treatment with this 
amphipathic compound caused a reduction in immunoreactivity to extracted LTAs, inhibition 
of recombinant LtaS in vitro, and inhibition of S. aureus growth in vitro and in a mouse 
infection model. However, compound 1771 exhibited a steep dose-response profile, none of 
several compound analogs tested retained activity, and they were unable to raise resistant 
mutants, all of which are characteristics of compounds that work non-specifically to disrupt 
the bacterial membrane. Nevertheless, we were interested in using compound 1771 to help 
elucidate the functions of LTAs and screen for genes that are synthetic lethal with LTA 
depletion. In order to examine the effect of compound 1771 treatment on cells, we first 
determined the MIC in S. aureus Newman to be 12.5 µM (growing overnight at 37°C), 
similar to that reported. We also attempted to raise resistant mutants on agar plates 
containing 15µM compound 1771 in wildtype, ΔtarO, and ΔltaS4S5 backgrounds over 24 hrs 
at 37°C, but were unable to obtain any colonies, suggesting resistance frequencies <10-9 and 
similar to the results reported for wildtype strains. As the ΔltaS4S5 strain is missing the 
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putative target of compound 1771 and has a suppressor mutation enabling the growth of cells 
without LTAs, we hypothesized that this compound has off-target effects. 
 
To further examine the effects of compound 1771 on cellular morphology and 
growth, we treated cells with 15µM compound for 2.5 hrs at 37°C and examined their 
phenotypes using transmission electron microscopy. In contrast to reports and observations 
of LTA-deficient strains, which exhibit noticeable defects in cell size, septation, and 
separation, the wildtype strain appeared normal in size and formed cells with single septa 
(Figure A.1). However, these cells exhibited a greater number of mesosomes than untreated 
cells, and appeared to have defects in cell membrane ultrastructure. This was less true for the 
ΔdltA mutant, which appeared similar to untreated cells and retained a small presence of 
ghost cells. Strikingly, treated ΔtarO cells exhibited increased lysis in comparison to 
untreated cells. It also septated in contrast to ΔltaS4S5  cells treated with tunicamycin. Though 
these results argue that compound 1771 does not phenocopy ltaS deletion, it is important to 
consider that small molecule inhibition of LtaS would slowly deplete cells of LTAs. Though 
we waited approximately 5 doubling times until sample collection, it is possible that residual 
LTA remains. To further analyze the effect of slowly titrating out LtaS activity using a 
genetic approach, one could construct a strain with ltaS under a tightly-controlled and 
inducible promoter and examine phenotypes of cells collected over a time course of 
depletion. 
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Figure A.1: Electron microscopy of cells treatd with 15µM compound 1771 and grown for 
2.5 hours at 37°C. (A) Wildtype cells; (B) ΔtarO; (C) ΔdltA. Scale bars represent 500 nm. 
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